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bred and kept track of all of the rats that those cells came from.  Peggy, Sharon V., and 
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people from Mike Kilbourn’s lab, Phil, Carole, Tim, and Dave, for tolerating many long 
days of planar gamma imaging. 
 I owe a great deal of gratitude to Yu-Ping Su, because without him I may have 
written these words a year from now.  He was here for a year to learn the ropes of 
research, and I am not sure that sectioning plastic blocks for hours on end for many 
months is exactly what he had in mind.  Not only did he do that, but he also took over the 
pilot study for the continuation of this project, he learned the surgical procedure (not too 
hard considering that he was already a great surgeon), and he developed the IHC protocol 
(which you will see later on in the thesis).  All of this was a tremendous help, and I owe 
him a great deal of thanks.  Yu-Ping,   
I have also benefited from the help of many students who have passed through the 
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Musculoskeletal injury poses a major health care burden in the United States.  
Health care costs for musculoskeletal injury in 2004 were $127.4 billion, an increase of 
37% from 1996.  Although it is difficult to determine exact numbers, it has been 
consistently reported that 60%-67% of all injuries in the U.S. involve the musculoskeletal 
system, and 25% of musculoskeletal injury treatment episodes are for fractures.  In 2004, 
four percent of people reported that a musculoskeletal injury limited their daily activities, 
and there were a total of 72.1 million days of work lost due to injury.  The hospital cost 
for fractures is greater on average than for other injuries.  Fractures accounted for 81% of 
patients hospitalized with a musculoskeletal injury, yet they represent 88% of related 
costs.  Fracture patients remained in the hospital for an average of 5.1 days at a cost of 
$27,740 per day for a total 4.3 million days and $23.44 billion [1]. 
Military trauma provides another incentive for new interventions in fracture 
healing.  Modern warfare has posed interesting challenges in bone repair.  With advances 
in critical care and the advent of new body armor, which protect the body’s core systems, 
75% of war injuries now involve the extremities [18, 66, 77].  These injuries often 
involve severe circulatory damage, major soft tissue trauma, and bacterial contamination 
[65] leading to a more challenging microenvironment for bone healing.   
Based on these data, methods to accelerate the repair of bone under both normal 
and challenging circumstances would benefit a large segment of the population.  With the 
burden of musculoskeletal injury increasing in both civilian and military lives, a better 
understanding of the mechanisms involved in fracture healing is needed to improve the 
treatment of bone injury.  The work presented in this dissertation aims to explore how the 
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mechanical environment, an important variable in the success of bone repair, affects the 
progression of healing and how this environment may influence cells involved in the 
repair process. 
Biologic Fracture Healing Progression 
Normal fracture healing is a process unique from typical wound healing in that 
there is a complete reconstitution of the bone without the formation of scar tissue.  This 
process is complex involving numerous cell types, and many different factors influence 
healing progression.  These factors are related to the physical nature of the fracture 
(severity, location), the biologic environment at the fracture site (vascularity, growth 
factor and cytokine availability), nutritional, physical, and genetic.  Mechanical factors 
such as interfragmentary strain and rigidity of fixation as well as fracture geometry have 
also been shown to effect the progression of healing [9, 24, 108]. 
Fracture healing can progress through one of two methods, primary or secondary 
healing.  Primary fracture healing occurs when there is little interfragmentary strain 
between points of repair and there are areas of bony contact in conjunction with gaps 
along the fracture.  In primary healing, the cortex attempts to directly restore itself by 
bridging the fracture gap.  Mesenchymal progenitor cells differentiate into osteoblasts 
and lay down osteoid along the exposed surfaces.  Once initial bridging occurs, returning 
continuity and providing points of contact between the two halves, osteoclasts form 
cutting cones across the gap recreating the Haversian system and reestablishing 
vascularization.  The return of the blood supply allows for the delivery of endothelial and 
mesenchymal progenitor cells, which establish new osteons further stabilizing the 
fracture.  For a fracture to heal through primary healing alone is rare since it is very 
difficult to fix a fracture without some motion occurring between the two bone ends.  
Therefore most fractures mend through a combination of primary and secondary fracture 
healing.  [27, 29, 82] 
Secondary fracture healing occurs through both intramembranous and 
endochondral bone formation, mimicking embryonic bone development.  Normally, bone 
forms through intramembranous ossification on the callus periphery and through 
endochondral ossification adjacent to the bone with the periosteum and surrounding soft 
tissues contributing to the healing response.  This healing occurs in non-discrete stages 
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until lamellar bone bridges the fracture gap to completely restore mechanical stability.  
The immediate response to fracture is the formation of a hematoma and inflammation.  
This response serves to initially provide stabilization between the two bone ends and to 
initiate signaling cascades vital to the healing process.  After the hematoma has formed, 
precursor cells invade to form new blood vessels, fibroblasts, and other supporting cells 
that form granulation tissue between the fractured ends.  Macrophages and other cells 
derive from this tissue and act to remove the original hematoma.  Osteoclasts then begin 
to resorb the damaged and necrotic bone ends, and osteoprogenitors from the periosteum 
proliferate.  Through intramembranous ossification, these osteoprogenitors form woven 
bone creating a hard callus on the periphery.  At the same time, cells from the periosteum 
and surrounding tissues begin to form cartilage within the granulated scaffold, this 
cartilage matrix mineralizes, and bone forms through endochondral ossification.  Finally, 
the woven bone that now constitutes the fracture callus is remodeled to return the bone to 
its original state.  [27, 29, 37, 82] 
Expression of Molecular Factors During Fracture Healing 
Many different molecules are necessary to drive the fracture repair process.  The 
presence and timing of the regulation of these molecular factors determine the overall 
progression of stages in secondary fracture healing.  These promoting and signaling 
molecules can be classified into three groups: the pro-inflammatory cytokines, the 
transforming growth factor-beta (TGF-!) superfamily and other growth factors, and 
angiogenic factors [28, 118]. 
Bones express several different cytokines after injury that intact bones do not, 
suggesting that the fracture event triggers the release of cytokines that begin the process 
of healing [30].  The inflammatory cascade that occurs within the first 24 hours after 
injury is important because without this response the bone will not heal [95, 102].  
Interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-"), and 
macrophage colony stimulating factor (M-CSF) are all present during the initial stages of 
healing [28, 29, 64, 91, 118].  These inflammatory factors are secreted by macrophages 
and other inflammatory cells and also by cells of mesenchymal origin [28, 118].  They 
have many functions including the recruitment of inflammatory cells, regulation of the 
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extracellular matrix, the stimulation of new vessel formation, and chemotactic effects on 
fibrogenic cells and mesenchymal stem cells (MSCs) [28, 91, 118].  
Growth factors also play an important role in early fracture healing.  TGF-! and 
platelet derived growth factor (PDGF) are released from degranulating platelets and 
regulate proliferation and differentiation of MSCs [3, 14, 29, 38, 57, 95].  Bone 
morphogenetic proteins (BMPs) have also been shown to be expressed early in the 
healing process, especially BMP-2 and BMP-4 [87, 88].  BMPs originate primarily from 
the extracellular matrix, but are also released from osteoprogenitor cells and osteoblasts.  
They regulate the differentiation of MSCs into chondrocytes and osteoblasts and 
osteoprogenitor cells into osteoblasts [13, 28, 95].  BMPs may also be important in the 
signaling mechanisms that link mechanical forces to a biologic response [45, 99, 104].  
Fibroblast growth factors (FGFs) are released from macrophages, MSCs, chondrocytes, 
and osteoblasts and may only become available after cell injury or death [95, 102].  FGFs 
are mitogenic factors that help maintain the proliferation of MSCs, chondrocytes, and 
osteoblasts [14, 91, 95].  Insulin like growth factor-I and -II (IGF-I and -II) are also 
released early in the repair process [2, 28], and are involved in the proliferation and 
differentiation of osteoprogenitor cells [95].  
There are thousands of other genes that are either up- or down-regulated during 
the repair process [47].  Matrix metalloproteinases (MMPs), vascular endothelial growth 
factors (VEGFs), angiopoietin-1 and -2, and hypoxia-inducible factor-1 (HIF-1) work 
together to provide vascularization to the fracture site [28, 78, 118].  Indian hedgehog 
(Ihh) and its signaling molecules are important in chondrocyte differentiation and 
maturation and have been shown to be expressed throughout the first several weeks of 
healing [54, 72, 86].  Some other important proteins involved include extracellular matrix 
proteins like osteonectin, alkaline phosphatase, osteocalcin, and various collagens and are 
important in restoring the cartilage and bone matrices [49, 56].  There are many complex 
interactions and many other important molecular events involved in fracture repair, and it 
is too broad a scope to cover them at this time. 
Mechanotransduction in Bone 
Mechanotransduction is the means by which a mechanical signal is sensed and 
converted into a biochemical reaction.  Since the late 1800’s, when Julius Wolff proposed 
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that the form of bone follows its function, it has been postulated that bone is responsive 
to mechanical cues, but the means by which bone senses these cues is still not 
understood.  Cells have been proposed to sense mechanical force through several 
different mechanisms, and there is some debate about which mechanism is most likely to 
elicit a biochemical response. 
One theory proposes that cells sense force through direct stretching at integrin 
binding sites, which may be caused by deformations of the extracellular matrix to which 
they are attached [107].  There are even differing view among those who believe this is 
the cell’s primary means of sensing and responding to mechanical stress.  Some believe 
that cytoskeletal elements form a “tensegrity” structure that transmits forces through a 
prestressed cytoskeletal linkage [52].  Other investigators believe that the cell should be 
viewed as a continuum with an elastic cortex and a viscous cytoplasm.  The continuum 
model relies on the fluid behavior of cells, whereas the tensegrity model assumes a less 
viscous approach [53].       
The other two proposed mechanisms each involve flow of interstitial fluid 
through the lacuno-cannalicular network.  Through molecular tracer methods, fluid flow 
through these channels has been shown to be induced by load in vivo [115], and several 
mathematical models have been developed to describe this phenomenon [110, 111].  In 
the first proposed model, interstitial fluid is forced through the lacuno-cannalicular 
network by strain gradients, placing a fluid shear stress on osteocytes housed in lacunae 
[17, 42].    It is then this fluid shear, and not bulk strain, that causes a cellular response.  
The second fluid flow hypothesis assumes that diffusion of nutritive molecules is not 
enough to sustain viable osteocytes [114].  Instead, nutrient delivery is enhanced as 
molecules are carried to osteocytes via the extracellular fluid [115]. 
Mechanical Stimulation of Fractures 
The mechanical environment of a fracture site has been known to play an 
important role in fracture healing and tissue differentiation for many years [21].  Pauwels 
recognized that distortional and hydrostatic stress played an important role in tissue level 
signaling.  He concluded that hydrostatic compression drove cartilage formation, but that 
no specific mechanical stimulus drove bone formation.  In 1979, Perren proposed the 
concept of interfragmentary strain, in which tissue response was dependent on strain 
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magnitude [92, 93].  If a tissue fails at a lower strain than is imposed within the fracture 
site, that tissue cannot form [20]. 
Appropriately applied mechanical conditions have been known to accelerate 
fracture healing [44, 60, 61, 103], and there are many mechanical properties that 
influence the healing process including strain rate, frequency, magnitude, number of 
cycles, and number of days of stimulation among others.  The sizeable number of 
possible variables involved leads to a wide discrepancy in results between experiments.  
It also leads to a variance in experimental models and design. 
Some experimental designs passively alter the motion at the defect changing only 
the stiffness of the fixation, either by altering the properties of the fixator or by delaying 
fixation.  Most of these studies show that an increase in motion produced by less stiff 
fixation creates a larger callus, but this increase in callus size does not lead to superior 
healing [62, 98, 124].  The result is the same if stabilization is delayed, as early weight 
bearing with limited fixation leads to larger, cartilaginous calluses with less mechanical 
integrity [7, 84].  These results are supported by increased and prolonged chondrogenesis 
in fractures with greater motion, and increased bone formation in defects with more rigid 
fixation [43].  This is contrary to a study by Goodship et. al. [41], which found that an 
increase in fixator stiffness reduced the rate of healing.  These studies show that the 
properties of the fixation device itself and the timing of fixation influence callus 
attributes. 
The majority of investigations into the effects of the local mechanical 
environment on bone repair actively control the motion at the defect.  These devices 
allow for a prescribed motion at set time points.  Normally, these devices are powered by 
an external actuator or through a sliding mechanism that allows a set motion to occur 
during normal ambulation, which is called dynamization.  Experiments designed with a 
dynamization fixator allow for motion at the fracture site via the forces created from 
normal ambulation with a nut or other locking mechanism set to allow a desired 
maximum strain.  Studies using this model have found that larger fracture gap sizes lead 
to poorer fracture healing and that gap size plays a significant role in the progression of 
repair [6, 24, 126].  These studies also showed that small controlled movements in 
smaller gaps can increase bone formation [126], callus size [24, 25], and tensile strength 
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[25].  The disadvantages of this model are that the motion is limited to compressive 
strains, and over time, the motion will decrease as healing progresses and tissues 
progressively fill the defect, altering the experimental conditions. 
Experiments designed with external fixation providing controlled motion with 
mechanical actuation allow for the study of both compressive and tensile strains on 
fracture healing.  These experiments also ensure that the same strain is applied across the 
gap regardless of change in stiffness.  These studies found that fractures subjected to 
cyclic compression demonstrated higher torque and energy to failure, higher torsional 
stiffness, more advanced tissue differentiation, and more complete bony bridging than 
their rigidly fixed counterparts [40, 122].  Having active control over the motion also 
allows for the examination of many different experimental parameters.  For example, 
Goodship et. al. [39] examined the influence of strain rate on healing and found that a 
short term, high strain rate applied early in the healing process encouraged a larger 
periosteal callus than fractures stimulated at a low strain rate.  The direction of strain has 
also been shown to cause a different response in callus formation using these models.  
Studies have suggested that compressive strains encourage peripheral or periosteal callus 
formation, distractive strains allow more central callus formation, and fully reversible 
strains encourage both peripheral and interfragmentary callus formation [48, 112]. 
Not all studies have concluded that mechanical stimulation influences the 
reparative process.  Some studies have shown that the chosen stimulus did not affect 
fracture healing.  In an early study, White, Panjabi, and Southwick did not find any 
mechanical differences in osteotomized rabbit tibiae loaded in either constant 
compression or cyclic compression for four hours per day, seven days per week, when 
compared to sham controls [121].  This same conclusion was drawn in studies applying a 
variety of different controlled micromotions at many different frequencies, as well as 
with applied axial dynamization [5, 8, 123].  Although there are some studies that suggest 
that changing the mechanical environment in a healing fracture may not have an effect, 
the wide array of literature speaking to the contrary provides strong evidence that 
micromotion plays a vital role in fracture repair.     
Many studies have also attempted to relate the local mechanical environment in a 
fracture gap to tissue differentiation patterns though finite element modeling (FEM).  
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These can range from simple models incorporating only solid tissue properties to more 
complicated biphasic models that simulate fluid effects along with tissue strains [71].  
Carter et. al. believe that bone formation occurs in areas of low to moderate tensile strain, 
cartilage formation occurs under hydrostatic pressure, and fibrous tissue growth occurs in 
areas of moderate to high tensile strain [76].  Claes and Heigele [23] hypothesized that 
small strains and small hydrostatic pressures (<±0.15 MPa) lead to direct bone formation, 
compressive hydrostatic pressures above 0.15 MPa lead to chondrogenesis and therefore 
endochondral ossification, and all other stimuli lead to connective tissue or fibrocartilage 
formation.  In contrast, Smith-Adaline et. al. [108] concluded that tensile strains promote 
endochondral ossification and that compressive strains promote intramembranous 
ossification. 
Mesenchymal Stem Cells 
Ten years after the characterization of hematopoietic stem cells [73], Friedenstein 
and colleagues first described in vitro what they referred to as colony-forming units, 
which are better known today as mesenchymal stem cells [36].  Mesenchymal stem cells 
are pluripotent cells which give rise to tissues of mesodermal origin such as bone, 
cartilage, muscle, ligament, tendon, adipose, and stroma [10, 15, 19, 46, 96].  There is 
also evidence that they can give rise to cells of ectodermal and endodermal origin such as 
neurons and hepatocytes [68]. 
Mesenchymal stem cells have a therapeutic advantage over some other types of 
cells because they can be easily isolated and expanded through bone marrow aspiration 
with little pain [90].  MSCs also possess an immunomodulatory effect towards many 
immune effector cells including some T-cells, B-cells, natural killer cells, monocytes, and 
dendritic cells [67].  With regard to fracture healing, the bone marrow and periosteum are 
rich sources of MSCs with the most activity occurring in metaphyseal bone and vascular 
periosteum [69].  It may be advantageous to use MSCs to augment fracture repair, since 
they are involved in every aspect of bone regeneration [69]. 
MSCs have been used to repair critical sized, segmental bone defects in vivo [4, 
16, 63, 69, 94].   These cells have also been shown clinically to increase bone mineral 
content and growth velocity in children with severe osteogenesis imperfecta [50, 51].  
MSCs have also been used to treat defects in tissues other than bone including traumatic 
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brain injury [79-81], infarcted myocardium [89], and cerebral ischemia [22, 120] 
demonstrating the diverse promise for tissue repair that these cells possess.  
Mesenchymal Stem Cell Migration and Homing 
Many investigators have explored different factors that may be involved in 
mesenchymal stem cell migration.  The most common assay to determine if MSCs will 
migrate toward a given agent is a modified Boyden chamber assay [101].  In this 
technique, two wells are separated from each other by a filter.  Medium containing the 
potential chemoattractant is placed in the bottom well, and the MSCs are seeded into the 
upper chamber in plain medium.  The number of cells that migrate through the filter can 
then be counted to determine how strong a migratory stimulus was present.  Although 
this is one of the most common experiments to determine factors involved in migration, 
there are also other experiments, including in vivo injury and cancer assays that can be 
used to examine stem cell migration [31, 83]. 
Through these assays, many different regulators of MSC migration have been 
recently identified.  The most commonly studied may be stromal cell-derived factor-1 
(SDF-1).  SDF-1 is expressed in the bone marrow by osteoblasts, fibroblasts, and 
endothelial cells [58].  It has been shown that there is a population of MSCs that express 
CXCR4, the unique receptor for SDF-1, and that these cells migrate toward SDF-1 [11, 
26, 55, 70, 74, 97, 100, 105, 106, 125]. 
There are many other factors that have been implicated in the migration of MSCs.  
Growth factors, such as TGF-!, BMPs, PDGFs, FGFs, and IGFs, which may be released 
during remodeling and injury, have been shown to induce migration of MSCs [12, 28, 32, 
33, 35, 74, 75, 90, 97, 106, 113, 116, 117].  MSCs have also been shown to migrate 
towards VEGFs, angiopoietins, and placental growth factor-1 (PlGF-1), which are 
important in restoring vascularization to the fracture site [28, 34, 106].  Factors that are 
released as part of the initial inflammatory response may be involved in recruiting MSCs 
to the injury site early in repair [12, 28, 58, 85, 100, 106, 119, 120].  Matrix 
metalloproteinases (MMPs) and bone sialoprotein (BSP) may permit the movement of 
MSCs through the bone matrix by mediating matrix degradation [31, 59].  Along with the 
chemokines, growth factors, and other factors mentioned above, there are numerous 




 Fracture healing is a complex process involving numerous cell types, and a 
variety of spatially and temporally related regulators.  Mechanical forces have been 
shown to play an important role in the extent and character of the repair process.  While 
prior studies have investigated the effect of physical forces on cell differentiation, 
biofactor expression, and mechanical competence of repair, the mechanosensory and 
response mechanisms are poorly understood.  The goal of this work was to explore the 
effects of an externally applied mechanical stimulus on fracture healing.  Specifically, 
changes in callus morphology and mesenchymal stem cell migration to the callus were 
examined with respect to the timing of the application of an axial displacement. 
 The mechanical environment is known to play an important role in the course of 
fracture repair.  Chapter 2 examines how callus morphology is altered by an external 
stimulus.  The effect of the timing of the applied stimulus was determined by quantitating 
differences in tissue formation as well as the torsional strength of the healing fracture.  
Chapter 3 examines the potential effect of a mechanical stimulus on the migration of 
systemically delivered mesenchymal stem cells to the fracture sites.  Nuclear imaging and 
immunohistochemistry were used to determine the short- and long-term fates of the 
delivered cells.  Finally, Chapter 4 analyses the differential regulation of genes that have 
been implicated in MSC migration.  Using a high throughput polymerase chain reaction 
assay, expression of genes previously implicated in MSC recruitment was compared in 
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The Effects of Axial Displacement on Fracture Callus 
Morphology Depend on the Timing of Application 
 
 
Normal fracture healing is a process unique from typical wound healing in that 
there is a complete reconstitution of the bone without the formation of scar tissue.  This 
process is complex involving numerous cell types, and many different factors influence 
healing progression.  These factors are related to the physical nature of the fracture 
(severity, location), the biologic environment at the fracture site (vascularity, growth 
factor and cytokine availability), and the nutritional, physical, and genetic state of the 
individual sustaining the fracture.  Mechanical factors such as interfragmentary strain and 
rigidity of fixation as well as fracture geometry have also been shown to effect the 
progression of healing [1, 5, 22].   
Appropriately applied mechanical conditions have been known to accelerate 
fracture healing [10, 15, 16, 21], and there are many mechanical factors that are known to 
influence the fracture repair process including strain rate, frequency, magnitude, number 
of cycles, and number of days of stimulation among others.  The sizeable number of 
possible variables involved leads to a wide discrepancy in results between experiments.  
It also leads to a variance in experimental models and design. 
There are a wide variety of experiments and models that have been used to study 
mechanical influences on fracture healing in vivo.  Studies using fixation that allow for 
dynamization, which use a fixator to control the amount of displacement allowed during 
normal ambulation, have found that small controlled movements can increase bone 
formation [27], callus size [5, 6], and tensile strength [6].  Models that actively control 
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the displacement through actuated external fixators have found that fractures subjected to 
cyclic compression demonstrate higher torque and energy to failure, higher torsional 
stiffness, more advanced tissue differentiation, and more complete bony bridging than 
their rigidly fixed counterparts [9, 26].  These models also suggest that compressive 
strains encourage peripheral or periosteal callus formation, distractive strains allow more 
central callus formation, and fully reversible strains encourage both peripheral and 
interfragmentary callus formation [12, 23]. 
While prior studies have investigated the effect of physical forces on cell 
differentiation, biofactor expression, and mechanical competence of repair, the 
mechanosensory and response mechanisms are poorly understood.  The purpose of this 
study was to evaluate the temporal effect of a controlled mechanical environment on 
fracture repair with a systemic cell delivery.  Specifically, this study was designed to 
investigate how the timing of an applied axial displacement following a femoral 
osteotomy affects callus morphology and the mechanical properties of the healing 
fracture site. 
Materials and Methods 
Animal Surgery and Mechanical Stimulation 
One hundred ten, six-month-old, male, Sprague-Dawley rats underwent a 2mm 
segmental osteotomy in the mid-diaphysis of each femur.  After a 1cm exposure and 
elevation of the soft tissues, four 0.062-inch diameter, 1.225-inch long threaded pins were 
placed through predrilled holes made in the diaphysis using a specialized guide.  The pins 
were made by cutting threaded Kirschner wire to the appropriate size, grinding a sharp 
point onto one end, and grinding four beveled surfaces on the other end.  The end with 
four faces allowed the pins to be threaded into the bone, while the sharp point allowed the 
pins to cut through the skin after they had been secured in the bone.  After the pins were 
placed, a two-piece external fixator with locking plate was then affixed to the pins.  An 
osteotomy was created with an oscillating saw under constant saline irrigation, and the 
surrounding tissues were then closed.  No infections were present in the animals at any 
time after surgery, and with some minor exceptions, the procedure was well tolerated by 
the animals.  (See Figure 2 - 1) 
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The fixators are comprised of three different pieces all of which are made from 
PEEK (Figure 2 - 2).  The main blocks have channels to accommodate the pins as well as 
a groove to align the locking plate along the axis of the fixator.  During surgery, after the 
pins were secured in the femur, the fixator was attached by clamping the pins between the 
main block and the pin plates.  The construct was held rigid by the locking plate 
connecting the two main blocks.  The fixator was released for axial stimulation by 
removing the locking plate, which was then reattached after every administration of 
displacement.  
Axial mechanical stimulation was performed with a linear precision table and 
servo controlled stepper motor.  The system provides controlled axial motion with 
displacement monitored by a linear variable differential transformer (LVDT).  The rats 
were placed in a sling so that the fixator could be properly aligned, and the locking plate 
was removed once it was secured in the loading device (Figure 2 - 1).  Axial 
displacement was applied to one randomly chosen limb, while the other femur served as a 
contralateral control.  Mechanical stimulation occurred for five consecutive days 
beginning at 0, 3, 10, or 24 days post-operatively (groups A through D respectively) at a 
magnitude of ±8% strain (±0.16 mm) and a rate of 0.313 Hz for 510 loading cycles.  Rats 
were euthanized 10, 24, or 48 days post-operatively for a total of nine groups.  All groups 
had an initial size of 12 rats, with the exception of the group stimulated 24 days after 
surgery, which had an initial size of 14. 
Bone marrow was harvested from 2- to 4-month-old green fluorescent protein 
(GFP) transgenic rats and cultured in growth medium.  The mesenchymal stem cells 
(MSCs) cultered from the marrow were resuspended in 1 ml PBS at a concentration of 1 
million cells per ml prior to injection.  (See Chapter 3 for complete details on how the 
cells were cultured and prepared for injection.)  Systemic injections of these cells were 
performed via the tail vein immediately before mechanical loading, and data from these 
were collected for future analyses.  All experimental procedures were approved by the 
University of Michigan Committee on Use and Care of Animals. 
Microcomputed Tomography 
Immediately after sacrifice, both femora were excised and the surrounding soft 
tissue was removed without disturbing the callus around the fracture site.  A temporary 
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fixator was then placed adjacent to the existing fixator to facilitate the removal of the 
original fixator and central pins.  The original fixator and the two central pins were 
removed in order to both fit the specimen into the scanner and to eliminate metal from the 
volume to be scanned to reduce artifacts.  Bones were scanned via ex-vivo micro-CT (GE 
Healthcare Pre-Clinical Imaging, London, ON) at a voxel size of 18 microns.  After 
scanning, a region of interest was created encompassing the 2mm osteotomy site and any 
remaining cortical bone was subtracted from the region.  The lateral borders of the region 
of interest were defined by visible mineralization on the outermost boundary of the 
callus.  By analyzing image histograms, a gray scale value threshold of 1200 was chosen 
for all specimens to define bone voxels.  Any voxel with a gray scale value above the 
threshold was considered bone, while any voxel with a value below 1200 was not.  The 
micro-CT measures the amount of mineral in the specimen in Hounsfield Units, which 
are converted to bone mineral mass in milligrams through calibration using a 
hydroxyapatite standard.  The callus volume was defined as the volume of the created 
region of interest (units of mm
3
).  The bone volume was defined as the total volume of 
the voxels with a gray scale value above the threshold of 1200 (units of mm
3
).  The bone 
mineral content (BMC) is the mineral mass within the region of interest (units of mg), 
and the bone mineral density (BMD) is the mass of the mineral divided by the callus 
volume (units of mg/cm
3
).  The tissue mineral content (TMC) and the tissue mineral 
density (TMD) are similar to the BMC and the BMD except that they measure only the 
mineral content and density of the bone voxels, those voxels with a gray scale value 
above the set threshold (units of mg and mg/cm
3
 respectively).  Finally, the bone volume 
fraction (BVF) is the fraction of the callus volume that is bone (bone volume divided by 
callus volume).  Callus volume, bone volume, BMC, BMD, TMC, TMD, and BVF were 
recorded for each 2mm osteotomy and were used to determine densitometry differences 
in each fracture callus.  
Histology 
After micro-CT scanning, a set of five specimens per group was placed in 10% 
neutral buffered formalin for three days.  The specimens were then removed and placed 
into 70% ethanol until they were processed.  Specimens were embedded in poly(methyl 
methacrylate) and cut into 5µm thick, longitudinal sections at five different levels spaced 
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200-300µm apart through the thickness of the bone.  Sections were mounted and then 
stained using safranin-O and fast green to differentiate cartilage and bone. 
Six images per section were captured at 2.5 times magnification (Axiovert 200M, 
Carl Zeiss, Oberkochen, Germany) and stitched together using Photoshop (Adobe, San 
Jose, CA) in order to obtain a section overview.  One section per level was analyzed for a 
total of five sections per specimen.  Each image was cropped to a height of 2mm to 
correspond to the size of the original osteotomy, and a boundary was drawn 
encompassing the callus periphery to quantify the callus area per section.  Areas of 
cartilage and bone were quantified through color thresholding using the magic wand and 
histogram tools in Photoshop.  Areas were recorded as pixel counts, and bone and 
cartilage areas were normalized to the callus area for each section.  The values obtained 
for each section of the five levels per specimen were averaged to arrive at an average 
cartilage/callus area and bone/callus area for each bone. 
Torsion Testing 
 The remaining seven specimens per group (nine for the group stimulated 24 days 
post-operatively) were tested to failure in a custom designed torsion fixture.  The bone 
ends were secured in aluminum pots with molten bismuth that was then allow to cool.  
The pots were locked into each side of the testing apparatus, and the bones were hydrated 
with lactated ringers solution.  The gage length of each specimen was measured, the 
locking plate of the fixator was removed, and the bones were then tested to failure at a 
rate of 0.5 deg/sec.  A custom MATLAB (Mathworks, Natick, MA) script was then used 
to determine the stiffness, ultimate failure torque, failure twist, and energy to failure.  The 
stiffness was determined by picking points along the elastic curve to determine the slope 
(units of N-mm/deg).  The ultimate failure torque was chosen as the maximum torque 
achieved during the torsion testing (units of N-mm), and the failure twist was defined as 
the amount of twist at the ultimate failure point (units of deg).  The energy to failure was 




Statistical Analysis  
  A two-way, repeated measures ANOVA was run for all of the data using SAS 
(Cary, NC).  Differences for treatment (displaced versus control), timing of displacement 
initiation, and the interaction of treatment and timing were analyzed.  A Tukey-Kramer 
adjustment to correct for multiple comparisons was used to look for differences between 
loaded and control limbs independently at each euthanasia day.  The effect of slices was 
used to determine differences within groups.  Differences were deemed significant for 
p<=0.05.  All error bars represent plus or minus one standard error. 
Results 
 The final animal totals for each group are shown in Table 2 - 1.  Due to surgical 
complications, bone fractures at the pin sites, and specimens failing during processing, 
the final number of animals entered into the study is 99 out of a planned 110.  Table 2 - 1 
also explains the nomenclature for each group.  The letters correspond to the timing of 
the start of mechanical stimulation (0, 3, 10, or 24 days), and the numbers correspond to 
the day of euthanasia (10, 24, or 48 days) post-operatively. 
 The ratio of the stimulated to the control limbs shows decreases in all measures of 
mineralization for the groups displaced three days post-operatively (Figure 2 - 3).  This 
decrease was as high as 19% in the BVF for animals euthanized at day 48 (data not 
shown).  All other groups showed an increase in mineralization in the stimulated fractures 
when compared to the unloaded controls. 
 For rats that were sacrificed ten days after surgery (groups A10 and B10), there is 
a significant difference in the interaction of treatment and the timing of displacement 
(Figure 2 - 4).  In those animals, displacement decreased both the callus volume and 
BMC in fractures stimulated starting on day three (group B10), while stimulation 
increased the same measurements in fractures stimulated immediately after surgery 
(group A10).  The decrease between the loaded and control limbs within group B10 is 
significant for the callus volume, and the BMC within group A10 trends toward an 
increase (p=0.074).  
 When fractures are analyzed 24 days post-operatively, there is a strong trend for 
differences across all of the loaded limbs in BMC (p=0.055) and BMD (p=0.059).  
Looking for differences between individual groups reveals that there is less mineralized 
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tissue in the displaced fracture gaps of the animals stimulated on day three versus the 
animals stimulated on either day zero or day ten (Figure 2 - 5).  This difference reached 
significance for BMD between groups B (stimulation day 3) and C (stimulation day 10). 
 At day 48, there is a significant difference in the BMD (p=0.045) and BVF 
(p=0.049) across all the stimulated limbs (Figure 2 - 6).  Individually, there is a difference 
between the group displaced three days post surgery (group B48) and the group displaced 
ten days post surgery (group C48), with the loaded defects from C48 having more 
mineral than those in B48.  There is also a trend toward a higher TMD in group C48 than 
in B48 (p=0.068, data not shown).  Along with the increased mineral content in the 
fractures stimulated ten days post-op, there is a significant decrease in cartilage in the 
healing defect for that group (Figure 2 - 7 and Figure 2 - 8).  The loaded limbs in group 
C48 have significantly less cartilage than their contralateral controls (p=0.045), while the 
loaded limbs in group A48 have more cartilage than there contralateral controls 
(p=0.037).  There is also a difference in cartilage area between limbs stimulated at day 
ten and limbs that were stimulated at day zero (p=0.031) or day three (p=0.015).  (See 
Figure 2 - 9.) 
 Figure 2 - 10 shows that stimulation starting at day three (group B10) induced 
more cartilage formation by day ten than did stimulation immediately after surgery 
(group A10).  It also shows that the control limbs in the B10 group have a larger cartilage 
area than the controls from group A10 suggesting a possible systemic effect.  In animals 
euthanized on day 48, there is a significantly larger percentage of bone in the fracture 
gaps as measured by histology on both the loaded and control sides for the animals 
loaded starting on day ten (group C48) than for any other group (Figure 2 - 11).  
Independently, there is also more bone in the control defect of group C48 than for D48.  
This same pattern is seen in both the stiffness and torque at failure (Figure 2 - 12).  The 
bones from animals loaded on day ten are more stiff and stronger in torsion than bones 
from any other groups.  The controls from that group are also significantly stiffer and 
have a higher failure torque than the control bones from animals stimulated on day 24. 
Discussion 
  The application of an axial displacement has a definitive effect on fracture 
healing.  Specifically, the timing of the stimulus is an important factor in determining the 
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progression of callus morphology and mechanical properties.  Differences in healing due 
to displacement can be seen as early as ten days after fracture.  Fractures that were 
stimulated immediately had an increase in callus volume and bone mineral content and 
those that were loaded three days later had a decrease.  By day 24, the group that was 
displaced three days after surgery (group B24) had a decrease in mineralization on the 
displaced side in comparison to the other groups.  Forty-eight days after surgery, the 
group stimulated ten days post-op (group C48) had an elevated mineral content and 
almost no cartilage remaining on the stimulated side, while all the other groups still 
displayed a significant amount of cartilage. 
 The observation that the application of displacement on the animals soon after 
surgery decreased mineralization and mechanical properties in relation to the animals that 
had displacement starting on day ten suggests that axial mechanical stimulation may not 
be beneficial when it is started during the initial response to fracture.  Vascular supply is 
an important factor in determining the success of healing, and it has been suggested that it 
may be necessary to allow neovascularization to progress at the site of repair before 
mechanical load is applied [4, 24].  If motion is allowed too soon at the fracture site, the 
capillaries needed to support osseous tissues are constantly ruptured, and fibrocartilage 
formation is promoted since it requires less vascularization [19].  Therefore, it may be 
beneficial to the overall healing outcome to delay initiation of loading until new vessels 
have had a chance to form [8]. 
The results also suggest that it may be beneficial to start fracture stimulation after 
the inflammatory stage, when some soft tissues have had a chance to form.  After the 
initial inflammatory response, cells that may be responsive to load, such as chondrocytes 
[17, 20], have an opportunity to populate the fracture site.  A beneficial response to 
chondrocyte loading in fracture healing has been shown.  Scaffolds seeded with 
chondrocytes that were implanted in the femora of rabbits and then were compressively 
loaded had a higher bone volume fraction than the unloaded controls [3], showing that 
the application of a stimulus to a chondrocyte population may encourage bone formation 
at the site of repair. 
Mechanically, the local strain patterns induced by displacement are probably 
different between the animals that are stimulated soon after surgery and those that were 
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stimulated later.  The differences would be due to the different patterns of tissue 
formation present at the time of axial displacement.  When the displacement is applied at 
early time points, the only supporting structure in the gap is a loose, provisional matrix of 
granulation tissue.  In the absence of a stiff matrix, the applied stimulus may lead to not 
only high local tissue strains, but also high fluid shear stresses.  These high stresses may 
not be ideal for fracture healing, and the cells present may not be responsive to stresses of 
that magnitude.  As the fracture heals, a stiffer matrix begins to form, reducing the local 
magnitude of the applied stress.  By day ten, the cells that are in the fracture callus that 
may be responsive to load, like chondrocytes, may be receptive to the applied stimulus.  
These favorable conditions may be the reason for the beneficial response seen in group C, 
which was stimulated on day ten.  On day 24, the matrix would be substantially stiffer 
than it would be at any of the earlier time points, and the callus would have begun the 
early stages of mineralization.  The stiffness of the callus would reduce the magnitude of 
the local strain pattern, but the applied displacement may still be too great for the 
mineralized tissue to withstand.  This might lead to damage, and may explain the limited 
response of the group that was stimulated on day 24 (group D).      
 An interesting result from this study is the appearance of a systemic effect due to 
the local mechanical stimulus.  At day ten, the animals loaded three days post-operatively 
(group B10) exhibited significantly more cartilage as a whole (loaded and control 
combined) than those loaded immediately after surgery.  They also had more cartilage in 
the control limbs than those in group A10.  At day 48, the group loaded ten days post-op 
(group C48) had a significantly higher bone to callus ratio, stiffness, and failure torque as 
a whole when compared to all other groups suggesting that, in this group, the applied 
stimulus increased bone formation and mechanical properties in both the loaded and 
control defects.  This is consistent with findings that skeletal injury elicits an osteogenic 
response at distant sites [18].  Einhorn et. al. found that the mineral apposition rates in 
both tibiae of rats in which the right femur had been surgically injured increased as much 
as 350% over baseline controls [7].  Transverse loading of the knee has also been shown 
to accelerate healing in defects in the tibial diaphysis [28]. 
 This systemic response may be due to the release of soluble factors into the 
circulation as a result of the applied stimulus.  Matrix-metalloproteinase-1 (MMP-1), 
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basic fibroblast growth factor (bFGF), transforming growth factor !1 (TGF-
!1), insuin-like growth factor-I (IGF-I), IGF binding protein 3 (IGFBP-3), and human 
growth hormone (hGH) have all been shown to be increased in the sera of patients 
undergoing distraction osteogenesis [25].  Sera from fracture patients and patients 
undergoing distraction osteogenesis have also been shown to promote proliferation of 
osteoblasts, and TGF-! and IGF-I were shown to be important in those processes [13, 
14].  Increased proliferation of osteoblasts was only induced by sera of patients after the 
fractures had some time to heal, and proliferation was actually decreased when sera from 
the first week of healing was used [14].  Vascular endothelial growth factor (VEGF), 
which is important for the formation of new blood vessels, has been shown to be elevated 
in the muscles surrounding a distraction site as well as the muscles surrounding the 
contralateral control site [11].  It is feasible that the controlled displacement at the 
experimental site could increase the concentration of growth factors critical to fracture 
healing [29] in the bloodstream that would then influence the progression of repair in the 
contralateral osteotomy. 
 A complicating issue in the data analysis was the surprising amount of interanimal 
variability.  Figure 2 - 13 shows the difference, plus and minus one standard error, 
between values of the bone and callus volumes for the loaded and control limbs.  The 
error bars show the large amount of variability in the data.  This variability is not unusual 
in a segmental defect model [2], and may be confounded by performing a bilateral 
procedure.  Not only does the presence of two defects create two sources of variability 
per animal, but the systemic effects shown in this study also provide an increased source 
of variability at the contralateral site.  It may be beneficial for future studies to use a 
model with a unilateral defect and to use separate rats for stimulated and control groups.  
This may increase the number of rats needed per group, but will reduce the variability 
and make for a simpler surgical procedure. 
 In future studies, it may also be beneficial to test the mechanical properties of the 
callus in tension as opposed to torsion.  Torsion testing is a good measure of the 
functional properties of the callus under normal healing conditions, but it may not be the 
best measure in a model in which an axial stimulus is applied.  The applied stimulus may 
be causing directional healing where the bone is trying to reduce stress along the axis of 
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loading.  While a torsion test would include a component of any axial alignment, a test 
that looks specifically at properties along the long axis of the bone, like a tensile test, may 
be more appropriate due to the experimental conditions.  
 A controlled, axial stimulation has a definitive effect on fracture healing, and the 
timing of the application of the displacement differentially effects callus morphology and 
mechanical properties.  Stimulation early in the repair process was not beneficial to 
fracture healing, but when the displacement was applied starting ten days after injury it 
increased mineralization, accelerated callus remodeling, and increased torsional 
mechanical properties in comparison to other groups.  The beneficial effect was seen on 
both the experimental and the contralateral control defects, indicating that there may be a 
systemic effect from the applied stimulus.  These findings help to clarify the role of the 
timing of mechanical manipulation of fractures, and may help define parameters to be 
used in future fracture treatment.   
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Figure 2 - 1:  Overview of surgery and fixture for axial displacement.  A two-millimeter 
segmental osteotomy was made at the mid-diaphysis of each femur (a).  The fractures 
were stabilized using four threaded pins and a two-piece fixator that is locked in a rigid 
configuration for normal ambulation (b, c).  During axial stimulation, the rat was 
anesthetized, placed in a sling, and the fixator was aligned with the fixture clamp (d).  






Figure 2 - 2:  Overview of the fixator and pins.  During surgery, after the pins were 
secured in the bone, they were placed into the grooves in the main fixator blocks and 
locked into place with the pin blocks.  Rigid fixation was established by fastening the two 
main blocks together with the locking plate, which was removed during axial 








Figure 2 - 3:  Ratios of the average displaced and control mineralization values for each 
group.  All measures of mineralization, represented here by BMD and TMC, increased on 
the displaced side for all groups except the groups stimulated starting on day three  
(group B).  In those groups, decreases of up to 19% (in BVF, not shown) in the 
stimulated limbs in comparison to the undisplaced controls were observed.  For these 
values, comparisons can only be made between the stimulated and control calluses within 
each group because the control values are not necessarily equal across the groups due to 
an observed systemic effect caused by the applied displacement.  Differences between the 





Figure 2 - 4:  Displacement decreases callus volume and BMC by day 10 in animals 
stimulated three days post-op.  The plots show the interaction effect between the 
application of the displacement and the timing of the application of the displacement.  
The stimulus increased both callus volume and BMC in animals stimulated immediately 
after surgery (group A10), but had the opposite effect on animals loaded starting on day 
three (group B10).  The interaction between treatment and timing of stimulation was 
significant (p=0.050) signifying that the applied displacement acts differently on the two 
groups due to differences in when the stimulus was applied.  The callus volume in the 
displaced limbs of the animals loaded at day three was significantly lower than controls 
(p<0.050), and the BMC of the displaced limbs of animals loaded immediately displayed 





Figure 2 - 5:  Fractures stimulated three days post-op have reduced BMC and BMD on 
day 24.  In comparison to both the group displaced immediately after surgery (group 
A24) and the group displaced ten days after surgery (group C24), the group loaded 







Figure 2 - 6:  BMD and BVF are significantly higher in Group C (day ten displacement) 
versus Group B (day three displacement) 48 days after surgery.  In the later stages of 
healing, the mineral content is higher on the displaced side in the animals loaded ten days 
post-operatively than those at other stimulation time points.  This reached a significant 
increase over the defects displaced three days post-op, since the mineral levels in those 






Figure 2 - 7:  Cartilage area in animals euthanized 48 days post surgery.  After 48 days, 
there is cartilage remaining in all groups, both stimulated and control, except for the gaps 
stimulated ten days after surgery (group C48).  In these defects there is almost no 
cartilage remaining.  The differences were significant between the displaced limbs of 
A48 and B48 in comparison to C48.  There is also a significant difference between the 
displaced and contralateral control in group C48 (p=0.045), with the displaced side 
containing significantly less cartilage than the control.  There is also more cartilage in the 






Figure 2 - 8:  Histology for the group stimulated ten days after surgery (group C48).  
When the axial displacement is started ten days after surgery, the stimulated limbs have 
no cartilage and have bony bridging by day 48 (shown above).  The unstimulated controls 
have a substantial amount of bone, but still contain distinct areas of cartilage.  The figure 
shows: (a) a central section of a stimulated gap, (b) a peripheral section of a stimulated 
gap, (c) a central section of a control gap, and (d) a peripheral section of a control gap.  
Note that the difference in color between the top and the bottom images are an artifact of 






Figure 2 - 9:  Histology for the group stimulated three days after surgery (group B48).  
When the axial displacement is started three days after surgery, the stimulated and the 
control limbs have a substantial amount of cartilage remaining and bony bridging has not 
occurred at day 48 (shown above).  The figure shows: (a) a central section of a stimulated 
gap, (b) a peripheral section of a stimulated gap, (c) a central section of a control gap, and 





Figure 2 - 10:  Histology shows differences between control limbs at day ten, suggesting 
a systemic effect.  For animals euthanized ten days after surgery, there is an overall 
increase in cartilage area (stimulated and control combined) in the group stimulated three 
days after surgery (group B10) when compared to defects from animals stimulated 
immediately after surgery (group A10) (p=0.002).  The control gaps from these animals 
also display an increased amount of cartilage (shown above), suggesting that there may 






Figure 2 - 11:  Histology shows differences in normalized bone area from animals 
euthanized on day 48.  The group loaded ten days after surgery (C48) has a higher 
percentage of bone as a whole (stimulated and control limbs considered together) than 
any other group (p=0.005 with group A, p=0.010 with group B, and p=0.009 with group 
D).  There is also more bone in the control gap of C48 than in the control gap of D48 
(*p=0.011).  This suggests that the applied stimulus is promoting more bone formation in 






Figure 2 - 12:  Stiffness and torque at ultimate failure for animals euthanized on day 48.  
The group loaded ten days after surgery (C48) is stiffer (p=0.036 versus group A and 
p=0.004 versus group D) and had a higher torque at failure (p=0.024 versus group A, 
p=0.059 versus group B, and p=0.001 versus group D) than any other group.  The 
stiffness and ultimate failure torque are also higher in the control gaps of group C than in 
group D  (*p<0.05).  This suggests that the applied stimulus is promoting a more stiff and 







Figure 2 - 13:  High variance in fracture healing data.  This graph shows the differences 
in micro-CT outcomes between the displaced limbs and the control limbs for each rat 
averaged within each group.  Data from a bilateral, segmental defect fracture model show 
a high amount of variability, which can complicate analysis.  The bars represent plus and 












Displacement Initiation Day 
(Post-op) 
Euthanasia Day 10: 
Group Name (µCT, 
histology, torsion) 
Euthanasia Day 24: 
Group Name (µCT, 
histology, torsion) 
Euthanasia Day 48: 
Group Name (µCT, 
histology, torsion) 
A 0 A10 (n=11, 5, 5) A24 (n=12, 3, 7) A48 (n=8, 4, 4) 
B 3 B10 (n=11, 5, 5) B24 (n=11, 4, 5) B48 (n=10, 3, 7) 
C 10 -------- C24 (n=12, 5, 7) C48 (n=11, 3, 5) 
D 24 -------- -------- D48 (n=13, 5, 8) 
 
Table 2 - 1:  Table of group sizes.  This table shows the nomenclature for each group used in the study.  The letters correspond to the 
timing of mechanical stimulation, and the numbers correspond to the day of euthanasia.  The numbers in parentheses show the number 
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The Response of Systemically Delivered Mesenchymal Stem 




Ten years after the characterization of hematopoietic stem cells [24], Friedenstein 
and colleagues first described in vitro what they referred to as colony-forming units, 
which are better known today as mesenchymal stem cells [14].  Mesenchymal stem cells 
(MSCs) are pluripotent cells that give rise to tissues of mesodermal origin such as bone, 
cartilage, muscle, ligament, tendon, adipose tissue, and stroma [3, 5, 7, 16, 34].  There is 
also evidence that they can give rise to cells of ectodermal and endodermal origin such as 
neurons and hepatocytes [22]. 
Mesenchymal stem cells have a therapeutic advantage over some other types of 
cells because they can be easily isolated and expanded through bone marrow aspiration 
with little pain [31].  MSCs also possess an immunomodulatory effect towards many 
immune effector cells including some T-cells, B-cells, natural killer cells, monocytes, and 
dendritic cells [21].  With regard to fracture healing, the bone marrow and periosteum are 
rich sources of MSCs with the most activity occurring in metaphyseal bone and vascular 
periosteum [23].  It may be advantageous to use MSCs to augment fracture repair, since 
they are involved in every aspect of bone regeneration [23]. 
MSCs have been used to repair critical sized, segmental bone defects in vivo [2, 6, 
20, 23, 33].   These cells have also been shown clinically to increase bone mineral 
content and growth velocity in children with severe osteogenesis imperfecta [18, 19].  
MSCs have also been used to treat defects in tissues other than bone including traumatic 
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brain injury [25-27], infarcted myocardium [30], and cerebral ischemia [8, 37] 
demonstrating the diverse promise for tissue repair that these cells possess. 
Along with the availability of MSCs at the fracture site, the local mechanical 
environment is also known to be an important factor in the progress of repair.  Studies 
have found that small controlled movements can increase bone formation [39], callus size 
[9, 10], and tensile strength [10].  It has also been found that fractures subjected to cyclic 
compression demonstrated higher torque and energy to failure, higher torsional stiffness, 
more advanced tissue differentiation, and more complete bony bridging than their rigidly 
fixed counterparts [15, 38].  Experimental models have also suggested that compressive 
strains encourage peripheral or periosteal callus formation, distractive strains allow more 
central callus formation, and fully reversible strains encourage both peripheral and 
interfragmentary callus formation [17, 36]. 
Considering the significance of both progenitor cell availability and the 
mechanical environment on healing progression, it is important to understand whether the 
mechanical environment affects the migration of cells to the site of repair.  This study 
examines the effect that an externally applied mechanical stimulus has on systemically 
delivered mesenchymal stems cells.  Specifically, the study was designed to evaluate the 
migration of MSCs to sites of fracture repair and to determine if the timing of an 
externally applied, controlled displacement has an effect on the homing of these cells to 
the fracture site. 
Materials and Methods 
Seventy-nine, six-month-old, male, Sprague-Dawley rats underwent a 2mm 
segmental osteotomy in the mid-diaphysis of each femur.  Briefly, after a 1cm exposure 
and elevation of the soft tissues, four 0.062-inch diameter threaded pins were placed 
through predrilled holes made in the diaphysis using a specialized guide.  A two-piece 
external fixator with locking plate was then affixed to the pins.  An osteotomy was 
created with an oscillating saw under constant saline irrigation, and the surrounding 
tissues were then closed.  (See Chapter 2 along with Figure 2 - 1 for a full description.) 
Axial mechanical stimulation was performed with a linear precision table and 
servo controlled stepper motor.  The system provides controlled axial motion with 
displacement monitored by a linear variable differential transformer (LVDT).  The rats 
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were placed in a sling so that the fixator could be properly aligned, and the locking plate 
was removed once it was secured in the loading device (Figure 2 - 1).  For all the 
animals, mechanical stimulation occurred at a magnitude of ±8% strain (±0.16mm) and a 
rate of 0.313 Hz for 510 loading cycles. 
Bone marrow was harvested from 2- to 4-month-old green fluorescent protein 
(GFP) transgenic rats and cultured in growth medium containing 10% fetal bovine serum 
(Thermo Fisher Scientific (Hyclone), Waltham, MA) at 37°C, in 5% CO2, and 95% 
humidity.  Non-adherent cells were removed after 24 hours and the culture medium was 
changed three times per week.  After 12-14 days, the cells were released from the cell 
culture plate with 0.25% trypsin for 5 minutes, the trypsin was stopped with medium 
containing serum, and then the cells were replated at a density of 700,000 cells per 10cm 
culture dish.  After reaching confluence, the process was repeated.  Twenty four hours 
after the second passage, the standard growth medium was removed and replaced with a 
serum free defined medium consisting of a 60%/40% mixture of Dulbecco's Modified 
Eagle's Medium/MCDB201 (Invitrogen (Gibco), Carlsbad, California/Sigma-Aldrich, St. 
Louis, MO) containing 1% antibioitic/antimycotic (Invitrogen), 1% linoleic acid bovine 
serum albumin (Sigma), 0.01% platelet-derived growth factor-! (Cell Signaling 
Technology, Danvers, MA), 0.001% basic fibroblast growth factor (Cell Signaling), and 
0.05% insulin (Sigma).  In preparation for cell injection, the second passage cells were 
released with trypsin and resuspended in 1ml PBS at a concentration of 1 million cells 
per ml.  Systemic injections of these cells were performed via the tail vein immediately 
before the first application of axial displacement.  All experimental procedures were 
approved by the University of Michigan Committee on Use and Care of Animals. 
Planar Gamma Imaging 
Twenty-eight of the animals were selected to undergo planar gamma imaging to 
detect the short-term fate of the injected cells. 
111
Indium was added to the cell suspension 
prior to injection and allowed to diffuse into the cells for 30 minutes.  The suspension 
was then centrifuged and any free-floating 
111
indium was removed from the supernatant.  
Cells were injected prior to the first application of axial displacement, with the exception 
of group E in which cells were injected starting on load day four (see Table 3 - 1).   
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Mechanical stimulation occurred for three consecutive days starting 0, 3, 10, or 24 
days post-surgery.  After each daily loading cycle, the animals were scanned with a 
Gamma Imager SCT (Biospace, Paris, France).  Due to the scanner’s field of view, the 
upper and lower half of each animal was scanned separately.  Animals were euthanized 
after three days of displacement, with the exception of group E, which was euthanized 
one day after the prescribed displacement had ended.  
Regions of interest were created around each limb for each image using 
GammaVision+ (Biospace, Paris, France).  The regions for each animal were all of 
similar size and shape (Figure 3 - 1).  A circular region was also created in an area 
outside of the animal’s body to detect any background radiation.  The surface activity 
(counts per minute per mm
2
) was measured for each region of interest and recorded.  The 
surface activity (SA) for each region was then normalized by the background activity in 
order to determine a relative increase in activity for each limb.  A circular region was also 
created in a peak intensity region in the lungs in order to compare the amount of lung to 
limb radioactivity.  
Immunohistochemistry 
A group of 45 animals underwent axial displacement for five consecutive days 
beginning at 0, 3, 10, or 24 days post-operatively (groups A through D respectively).  
Rats were euthanized 10, 24, or 48 days post-operatively for a total of nine groups with 
five animals per group.  (See Table 3 - 2.)  After euthanasia, the rats’ femora were 
excised, the soft tissue surrounding the bones was carefully removed, and then the femora 
were placed in 10% neutral buffered formalin for three days.  The specimens were then 
removed and placed into 70% ethanol until they were processed.  Specimens were 
embedded in poly(methyl methacrylate) and cut into 5µm thick, longitudinal sections at 
five different levels spaced 200-300µm apart through the thickness of the bone.  The 
sections were mounted and left unstained in preparation for immunohistochemistry 
(IHC). 
After mounting, slides were deacrylized in a 1:1 mixture of xylene and 
chloroform for 30 minutes.  They were then rehydrated through a series of alcohol baths, 
and then decalcified in 8% formic acid for ten minutes.  After decalcification, the sections 
were incubated in a proteinase K solution for 30 minutes at 37°C (20 minutes at 
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temperature and then 10 minutes to cool the slides) to break the protein cross-links 
formed during formalin fixation.  The proteinase K solution was removed with a five 
minute water bath, and then the endogenous peroxidase was quenched with a 10:1 
mixture of methanol and 30% H2O2 for 30 minutes.  The sections were flushed twice with 
distilled water and then twice covered with PBS containing 0.1% Triton X-100 (TPBS) 
for five minutes each.  A blocking solution of 10% normal goat serum (Vector 
Laboratories, Burlingame, CA), in 0.02% TPBS containing 1.5% bovine serum albumin 
(BSA, Sigma) was then applied for 30 minutes at room temperature.  Then, a 1:1000 
primary antibody solution of rabbit anti-rat GFP (Fisher Scientific) diluted with 0.02% 
TPBS containing 1.5% BSA was placed on the sections and incubated at 4°C overnight.  
 After overnight incubation, the primary antibody was rinsed off with PBS and the 
secondary antibody solution of a 1:500 mixture of biotinylated goat anti-rabbit IgG(H+L) 
(Vector Laboratories) diluted with 0.02% TPBS containing 1.5% BSA was applied for 45 
minutes at room temperature.  The sections were then washed twice with PBS for five 
minutes and then incubated with Vectastain Elite ABC reagent (Vector Laboratories) for 
30 minutes at room temperature.  Then, they were washed twice in PBS for five minutes, 
incubated with stable DAB (Invitrogen) until the desired stain intensity was reached 
(usually two minutes), and rinsed in gently running tap water for five minutes.  Finally, in 
order to visualize the surrounding bone, sections were counterstained with fast green and 
cover slipped.  
Microcomputed Tomography 
Six additional animals underwent stimulation without an injection of exogenous 
MSCs beginning on day 24 to correspond with group D48 from the study in Chapter 2.  
(The group without cells will be labeled DNC.)  Immediately after sacrifice, both femora 
were excised and the surrounding soft tissue was removed without disturbing the callus 
around the fracture site (n=13 for group D48 and n=6 for group DNC).  A temporary 
fixator was then placed adjacent to the existing fixator to facilitate the removal of the 
original fixator and central pins.  The original fixator and the two central pins were 
removed in order to both fit the specimen into the scanner and to eliminate metal from the 
volume to be scanned to reduce artifacts.  Bones were scanned via ex-vivo micro-CT (GE 
Healthcare Pre-Clinical Imaging, London, ON) at a voxel size of 18 microns.  After 
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scanning, a region of interest was created encompassing the 2mm osteotomy site and any 
remaining cortical bone was subtracted from the region.  The lateral borders of the region 
of interest were defined by visible mineralization on the outermost boundary of the 
callus.  A gray scale value threshold of 1200 was chosen for all specimens to define bone 
voxels by analyzing image histograms.  Callus volume, bone volume, bone mineral 
content (BMC), bone mineral density (BMD), tissue mineral content (TMC), tissue 
mineral density (TMD), and bone volume fraction (BVF) were recorded for each 2mm 
osteotomy. 
Torsion Testing 
 Fourteen pairs of fractured femora were tested to failure in a custom designed 
torsion fixture (n=8 for group D48 and n=6 for group DNC).  The bone ends were 
secured in aluminum pots with molten bismuth that was then allow to cool.  The pots 
were secured on each side of the testing apparatus, and the bones were hydrated with 
lactated ringers solution.  The gage length of each specimen was measured, the locking 
plate of the fixator was removed, and the bones were then tested to failure at a rate of 0.5 
deg/sec.  A custom MATLAB (Mathworks, Natick, MA) script was then used to 
determine the stiffness, ultimate failure torque, failure twist, and energy to failure. 
Data Analysis 
A two-way, repeated measures ANOVA was run for the planar gamma imaging, 
micro-CT, and torsion data using SAS (Cary, NC).  Differences for treatment (displaced 
versus control), timing of displacement initiation, and the interaction of treatment and 
timing were analyzed.  A Tukey-Kramer adjustment was used to correct for multiple 
comparisons.  The effect of slices was used to determine differences within groups.  
Differences were deemed significant for p<=0.05.  All error bars represent plus or minus 
one standard error. 
For the IHC, three of the five levels per bone were used for a qualitative analysis.  
The levels chosen (levels one, three, and five) represent a symmetric view of the whole 
callus.  The sections were broken into eight different areas for analysis: the area 
physically within the fracture gap, the marrow area between the gap and the inside pin 
sites, the marrow area between the inside and the outside pin sites, the cortical bone 
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between the gap and the inside pin sites, the cortical bone between the inside and the 
outside pin sites, the periosteal callus between the gap and the inside pin sites, the 
periosteal callus between the inside and the outside pin sites, and the area surrounding the 
pin sites themselves.  The number of cells within each area was scored and then totaled.  
A score of zero corresponds to no cells present in that given area, a score of one 
represents 1-10 cells in that area, and a score of two signifies that 11 or more cells were 
present in a given area. 
Results 
 A detectable number of MSCs are delivered to both femora after a systemic 
injection of cells as measured by planar gamma imaging.  A high number of cells also 
remain in the visceral organs, especially the lungs, spleen, and liver.  Averaging all of the 
groups over all three days of imaging shows that on average the peak radioactivity in the 
abdominal organs was 4.2 times higher than in the femora.  Over the course of the three 
days, the cells began to migrate towards the lower extremities as can be seen in Figure 3 - 
2.  This pattern was not seen when 
111
indium was injected without first being incubated 
with MSCs (Figure 3 - 3). 
 In the femora, immediately after injection (displacement day one) there is a strong 
trend (p=0.0586) toward more activity in the stimulated femora in comparison to the 
controls regardless of when displacement was initiated (Figure 3 - 4).  On day one, there 
is significantly more activity in the stimulated limbs of the rats displaced on day three 
(group B) and a trend for more activity in the rats stimulated on day 24 (group D) (Figure 
3 - 4).  On the second day of loading, the timing of displacement administration with 
respect to the systemic injection of cells had a significant bearing on the migration of the 
MSCs, regardless of side (p=0.0079).  The group in which displacement did not start until 
three days after injection (group E) had significantly less activity on both the stimulated 
and control sides as compared to groups B (displacement day three) and D (displacement 
day ten) and a trend toward less activity when compared to group A (displacement day 
zero) (Figure 3 - 5).  By the third day of scanning, there were no differences within or 
between groups. 
 IHC shows that even though there is a small number of exogenous MSCs present 
throughout the healing process, the largest population of cells does not appear until 48 
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days after surgery (Table 3 - 2).  At that time, MSCs are detected in large populations 
throughout the marrow in the medullary canal (Figure 3 - 6) and the marrow spaces 
within the periosteal callus (Figure 3 - 7).  This is true for all of the groups euthanized on 
day 48 except for the group stimulated ten days post-op (group C).  It also appears that 
stimulation slightly increases the number of cells in the fractured limb, as the scores for 
the stimulated limbs were slightly higher than the control limbs at most time points 
(Table 3 - 3). 
To look at the effect that the cells may have on healing, a group in which 
exogenous cells were not injected was compared via micro-CT and mechanical testing in 
torsion to the group D48.  The group without cells had a higher bone volume, BMC, 
BMD, TMC, and BVF than the group with injected cells.  Stiffness and torque to failure 
were also higher in the group without exogenous cells as compared to the group that had 
cells delivered via the tail vein (Figure 3 - 8). 
Discussion 
Planar gamma imaging shows that many of the injected cells initially are detected 
in the lungs and liver.  This is probably due to the large number of cells delivered to the 
lungs all at once, and the cells are either sticking in the lungs or to each other as they 
attempt to make their way through the circulation.  If 
111
indium alone (without cells) is 
delivered via the tail vein under the same conditions that the cells were injected, the 
pattern of activity is more disperse and the lungs and liver do not see as high a level of 
activity (Figure 3 - 3).   
Despite the fact that the cell number initially prevents the cells from moving 
freely through the circulation, some of the cells do find their way to the injured limbs.  
They do not localize to the injury directly, but instead the activity seems to encompass 
the entire femur (Figure 3 - 1).  This may be due to the fact that the surgical procedure 
involves the placement of four bicortical pins to stabilize the fracture.  These pins may 
act as additional sites of injury that encourage the cells to populate the region around the 
entire femur as opposed to localizing to the osteotomy. 
The planar gamma images also show a transient difference in the radioactivity 
detected between different groups.  On the first day of axial displacement, the stimulation 
increases the activity in the loaded limbs versus the unstimulated controls.  That 
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difference disappears by day two, when no differences between the two sides are 
observed.  On day two though, there is a difference between all of the groups that 
underwent axial displacement immediately after cell injection and the animals in which 
cell injection was delayed until the fourth day of stimulation (group E).  This may suggest 
a transient systemic effect of load timing in relation to when the cells are delivered, as 
activity on both sides of the late delivered cell group showed a decrease.  This effect 
could be due to many factors.  The extra sessions of axial displacement could have 
triggered the systemic release of antimigratory factors (or hindered the expression of 
migratory factors).  Damage that could be induced by displacement could have 
accumulated over the course of the first three days and caused an adverse response.  This 
could especially be true in this group (group E) since displacement is not started until day 
24 and the mineralized tissue that is starting to form may not be able to tolerate the 
applied displacement.  It could also be that the animals that had the delay in cell injection 
could have experienced different stress factors, as they had to undergo three additional 
periods of anesthesia and stimulation in comparison to the other groups.  All of the 
radioactivity differences appear to be transient though, as there were no differences 
between any group by day three.  The inability to detect differences by that time point 
may also be due to a decline in sensitivity, as the half-life of 
111
indium is about three 
days, which would reduce the overall signal that can be detected. 
The sections stained for GFP through IHC confirmed that cells are able to migrate 
to the femora.  It also showed that the injected MSCs were, in most cases, able to 
establish a population in the marrow by day 48.  The exogenous MSCs were found in 
other locations other than marrow compartments (Figure 3 - 9), but it seems that the most 
consistent populations were found in the marrow.  This is probably because the marrow 
and the cambium layer of the periosteum are considered primary stem cell niches [23], 
and so it is natural for the cells to engraft there as opposed to other locations.  This is 
consistent with other studies that have found exogenous MSCs in the bone marrow for 
long periods after a systemic injection [13], and do not appear in large numbers in the 
first few weeks after delivery [32].  Most of these other studies though involve 
pretransplant conditioning like irradiation of the host animal [12], while few have been 
able to show long-term engraftment after bone marrow transplants without conditioning 
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[28].  Many studies deliver cells on a scaffold or genetically modify the cells before 
injection to increase healing or engraftment success [29], and our current study is one of 
the few to demonstrate long-term engraftment in the bone marrow and other tissues after 
a tail vein injection without host conditioning [11].  
The apparent higher number of cells in the bone marrow in comparison to other 
tissues may also be due to the available area of evaluation.  It could be that there is a 
greater opportunity for them to engraft or be detected in the marrow versus the cortices.  
There were a fair amount of cells detected in the cortices.  A common location for the 
cells to be detected in the cortical bone was the Haversian system as the cells move 
through the bone’s circulation as evidenced by cells travelling together along the same 
line.  This area though is much smaller than the marrow, so it may be that proportionally 
there were as many cells in the cortices as the marrow but the smaller numbers and area 
made them harder to consistently detect.  To prevent any skewing of results from this 
phenomenon, the results presented in Table 3 - 2 and Table 3 - 3 are from the marrow 
spaces only and do not represent areas of cortical bone. 
Probably the most curious result from these studies is that the presence of cells 
seems to have a deleterious effect on the fracture healing process.  The animals that had 
stimulation and cell delivery at day 24 exhibited less mineralization and lower 
mechanical properties in torsion than animals in the same group in which cells were not 
injected.  In this case, it could be that the actual delivery of the cells provided the effect.  
The animals that did not have cells delivered did not undergo a sham procedure, so it 
could be that the actual action of a needle stick and delivery of fluid, in this case PBS, 
caused an adverse effect.  It seems unlikely though that the act of injecting in the tail vein 
alone could cause such an adverse effect in healing bone defects in the femora. 
 The same deleterious effect can be seen in all of the groups except for the group 
that was stimulated starting on day 10 (Group C48).  In the current study, this group had 
the fewest amount of exogenous MSCs present around the fracture site.  In the previous 
study presented in Chapter 2, this group had the highest mineral content and displayed 
evidence of accelerated fracture healing.  For the case of group C48, it could be that the 
cells themselves had a problem, like a high population of cells that died in between cell 
preparation and injection, before or during delivery.  There were five different rats 
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examined by IHC in group C48.  Two of the rats were injected with one batch of cultured 
cells, and the other three rats were injected with a different batch of cells.  The only rat to 
exhibit strong populations of MSC was one of the first two rats, while none of the other 
rats showed signs of large MSC populations.  If the marrow from all the rats from one 
batch of injections had contained large numbers of MSCs, that would suggest a problem 
with the other batch of cells.  However, since four out of the five rats did not have an 
MSC population, it seems unlikely that a cell injection problem is the cause of this result. 
Since it is unlikely that the act of injection or problems with the cells is the cause 
of the adverse healing response, other hypotheses should be considered.  One plausible 
hypothesis is that the exogenous MSCs are preventing T-cells from proliferating at the 
fracture site.  MSCs act upon different subpopulations of T-cells, inhibiting T-cell 
proliferation but not their activation [35].  It has also been found that T-cells are recruited 
to the fracture callus during the inflammatory phase, and they may release cytokines and 
growth factors that are important in the progression of repair [1].  If the delivered MSCs 
are inhibiting T-cells from populating the area of the injury, this might explain the lower 
mineralization seen in the groups in which cells were delivered early on (groups A and 
B), but may not fully explain the response in the late delivered group (group D).   
Other hypotheses that could explain the decreases in healing involve a reaction 
from the host animal.  It could be that there is an immune response to the injected cells 
that is interfering with the healing process.  It is generally excepted that MSCs enjoy a 
certain amount of immune privilege [12], so it may not be that the host animal is trying to 
reject the injected cells.  It could also be that injected MSCs are somehow competing 
with the endogenous MSCs [4, 12] and instead of having a mutual beneficial effect, have 
a combined deleterious effect.   
This study has shown that mesenchymal stem cells delivered through the tail vein 
are capable of migrating to the site of injury.  The planar gamma imaging showed that the 
majority of cells initially reside in the visceral organs.  There was a population of cells 
that travelled out of these areas and into the femora, and mechanical stimulation seemed 
to have a transient effect on the migration of the cells.  Results from IHC demonstrated 
that in the long term, the exogenous MSCs form large populations in the marrow by 48 
days after surgery.  Mechanical stimulation immediately after the inflammatory phase 
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(stimulation on day 10) seemed to prevent these cells from engrafting and also improved 
healing in comparison to the other groups.  In addition, cell injections had a deleterious 
effect on fracture healing in animals that had cells delivered on day 24 (group D).  
Further study will need to be done to fully understand the mechanism by which the MSC 
are affecting bone fracture repair.  
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Figure 3 - 1:  Regions of interest encompassing radioactivity in the femora from planar 
gamma imaging.  Three regions were selected for each image acquired for the lower 
limbs.  The two rectangular regions encompass the femora, and the circular region is used 
to detect background signal.  The surface activity for each limb was measured and then 
normalized to the background signal.  The strong signal at the left of the image is 







Figure 3 - 2:  Systemically injected MSC migrate out of the lungs.  Immediately after 
injection of the MSCs, many of the cells are seen in the lungs.  On days two and three 
after injection, the cells can be seen more in the liver as the outline of the lungs has faded.  
The intensity of radioactivity, which is the measure for the size of the injected MSC 
population, is also decreased in the upper body by day three.  This could be due to both 
the MSCs migrating inferiorly out of the lungs and liver and to the half-life of 
111
indium, 
which is about three days.  The box around the internal organs on the illustration 






Figure 3 - 3:  Difference in radioactivity distribution with and without cells.  When 
111
indium is injected via the tail vein without being incubated with MSCs, the distribution 
of activity is different than when cells are injected.  The large number of cells delivered 
to the lungs may be the cause of the delay in the cells migrating out of the visceral organs 







Figure 3 - 4:  The normalized surface activity of the femora after the first application of 
axial displacement.  The displaced limbs in the rats stimulated starting three days after 
surgery (group B) showed an increase in radioactivity when compared to the unloaded 
controls (*p<0.05).  There was also a trend for an increase in the displaced limbs of the 









Figure 3 - 5:  The group that was injected with MSCs after three bouts of displacement 
(group E) shows less activity in both limbs than in any other group.  There was a 
significant difference for both the stimulated and control values across all groups.  The 
effect of load initiation was also significant for groups B and D when compared to group 
E (there was a trend between groups A and E).  This indicates that a smaller proportion of 
injected cells are available to both femora when the delivery of cells is delayed until axial 







Figure 3 - 6:  GFP positive cells in the marrow 48 days after surgery.  At all of the time 
points there was evidence of some GFP positive staining, but it was not until day 48 that 
there were large populations of GFP positive cells in the marrow spaces.  Cells were also 
present in other locations (cortices and pin sites), but the most consistent location for the 
MSC populations was in the medullary marrow and the marrow within the periosteal 







Figure 3 - 7:  GFP positive cells in the periosteal callus.  The injected MSCs populated 
any area that consisted of marrow spaces.  The areas in between the original cortex and 
the hard callus shell that formed from a periosteal response consist of marrow tissue.  The 
injected MSCs were often found in these areas.  The above image is of cells in the 










Figure 3 - 8:  Cells produce an adverse effect as measured by micro-CT and mechanical 
testing in torsion.  The group that was stimulated on day 24 but did not have exogenous 
cells introduced had a higher bone volume (p=0.017, not shown), BMC (p=0.025, not 
shown), BMD (p=0.011), TMC (p=0.014), and BVF (p=0.010, not shown) than the group 
that had cells injected via the tail vein on day 24.  The same decreases due to cell 








Figure 3 - 9:  GFP positive cells in cortical bone.  Even though the marrow contained the 
highest amount of GFP positive cells, other locations including the cortex (shown here) 




Chapter 3 Tables 
 
        Group 
Load Initiation 
Day (post-op) 




A (n=4) 0 0 2 
B (n=4) 3 3 5 
C (n=4) 10 10 12 
D (n=7) 24 24 26 
E (n=8) 24 27 29 
 
Table 3 - 1:  Explanation of the timing of axial displacement and cell injection for planar 
gamma imaging.  All of the animals were injected with MSCs via the tail vein 
immediately before the first application of mechanical stimulation with the exception of 
group E.  In that group, cell injection and planar gamma imaging began on the fourth day 
























A 0 0.25 0.51 0.74 
B 3 0.12 0.80 1.21 
C 10 ------- 0.73 0.54 
D 24 ------- ------- 1.40 
 
Table 3 - 2:  The score for the amount of MSCs detected in the marrow and the periosteal 
callus marrow for each group.  Sections were scored out of two, with a score of zero 
representing no cells present, one meaning that there were only a few cells (one to ten) 
cells present, and two signifying that there was an established population of cells present.  
The scores were then averaged within each group.  The highest number of cells was 
detected in the marrow spaces of the animals after 48 days.  The lone exception to this is 







Marrow and Callus: Cell 
Score for Stimulated Limb 
Marrow and Callus: Cell 
Score for Control Limb 
A10 0.22 0.29 
A24 0.52 0.50 
A48 0.87 0.62 
B10 0.13 0.11 
B24 0.90 0.70 
B48 1.38 1.04 
C24 0.88 0.57 
C48 0.67 0.42 
D48 1.58 1.43 
 
Table 3 - 3:  The scores for the amount of MSCs in the marrow spaces of the displaced 
and control limbs for each group.  The stimulated limbs have more cellular activity in the 
marrow when compared to the unstimulated control limbs.  The number of cells also 
increases with the amount of time after injection (i.e. A48>A24>A10), except in group C, 
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PCR Array for the Examination of Molecular Factors 
Implicated in Mesenchymal Stem Cell Homing 
 
 
Ten years after the characterization of hematopoietic stem cells [50], Friedenstein 
and colleagues first described in vitro what they referred to as colony-forming units, 
which are better known today as mesenchymal stem cells [26].  Mesenchymal stem cells 
are pluripotent cells which give rise to tissues of mesodermal origin such as bone, 
cartilage, muscle, ligament, tendon, adipose, and stroma [2, 8, 9, 32, 62].  There is also 
evidence that they can give rise to cells of ectodermal and endodermal origin such as 
neurons and hepatocytes [45].  With regard to fracture healing, the bone marrow and 
periosteum are rich sources of MSCs with the most activity occurring in metaphyseal 
bone and vascular periosteum, and MSCs are involved in every aspect of bone 
regeneration [46]. 
Through in vivo and in vitro assays, many different regulators of MSC migration 
have been recently identified.  The most commonly studied may be stromal cell-derived 
factor-1 (SDF-1).  SDF-1 is expressed in the bone marrow by osteoblasts, fibroblasts, and 
endothelial cells [40].  Recent data suggest that there is a population of MSCs that 
express CXCR4, the unique receptor for SDF-1, and that these cells migrate toward SDF-
1 [4, 18, 39, 47, 51, 63, 65, 68, 70, 83]. 
There are many other factors that have been implicated in the migration of MSCs.  
Growth factors, such as TGF-!, BMPs, PDGFs, FGFs, and IGFs, which may be released 
during remodeling and injury, have been shown to induce migration of MSCs [5, 19, 22, 
23, 25, 51, 52, 60, 63, 70, 74, 76, 77].  MSCs have also been shown to migrate towards 
VEGFs, angiopoietins, and placental growth factor-1 (PlGF-1), which are important in 
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restoring vascularization to the fracture site [19, 24, 55, 70].  Factors that are released as 
part of the initial inflammatory response may be involved in recruiting MSCs to the 
injury site early in repair [5, 19, 40, 56, 65, 70, 79, 80].  Matrix metalloproteinases 
(MMPs) and bone sialoprotein (BSP) may permit the movement of MSCs through the 
bone matrix by mediating matrix degradation [21, 41].  Along with the chemokines, 
growth factors, and other factors mentioned above, there are numerous others and their 
receptors [72] that have also been implicated in MSC migration. 
The mechanical environment of a fracture site has been known to play an 
important role in fracture healing and tissue differentiation for many years [11]. 
Appropriately applied mechanical conditions are known to accelerate fracture healing 
[31, 43, 44, 66].  Studies that apply a controlled stimulus across the fracture site have 
found that small controlled movements in smaller fracture gaps can increase bone 
formation [84], callus size [15, 16], and tensile strength [16].  Models that actively 
control the displacement through external fixation have found that fractures subjected to 
cyclic compression demonstrated higher torque and energy to failure, higher torsional 
stiffness, more advanced tissue differentiation, and more complete bony bridging than 
their rigidly fixed counterparts [29, 82]. 
Interestingly, it has also been shown that skeletal injury and stimulation elicit an 
osteogenic response at distant sites [53].  Einhorn et. al. found that the mineral apposition 
rates in both tibiae of rats in which the right femur had been surgically injured increased 
as much as 350% over baseline controls [20].  Transverse loading of the knee has also 
been shown to accelerate healing in defects in the tibial diaphysis [85], and distraction 
osteogenesis has been shown to increase growth and other soluble factors in the sera of 
patients [34, 42, 81].  The results outlined in Chapter 2 of this thesis also support that an 
axial displacement applied to a healing femoral fracture affects the repair of a fracture in 
the contralateral femur.   
Since both the mechanical environment and MSCs are known to be integral parts 
of fracture repair, it seems logical that changes in the mechanical environment can alter 
the migration of these cells.  Due to the wide range of biologic factors and mechanical 
stimuli that can affect fracture healing, the factors that encourage MSCs to migrate to the 
site of repair have not been fully studied.  The purpose of this study is to examine how 
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altering the local mechanical environment in an in vivo model of fracture healing affects 
the release of molecular factors that have been implicated in MSC migration. 
Materials and Methods 
Animal Surgery and Mechanical Stimulation 
Twelve, six-month-old, male, Sprague-Dawley rats underwent a 2mm segmental 
osteotomy in the mid-diaphysis of each femur (Figure 2 - 1).  Briefly, after a 1cm 
exposure and elevation of the soft tissues, four 0.062-inch diameter threaded pins were 
placed through predrilled holes made in the diaphysis using a specialized guide.  A two-
piece external fixator with locking plate was then affixed to the pins.  An osteotomy was 
created with an oscillating saw under constant saline irrigation, and the surrounding 
tissues were then closed. 
Axial mechanical stimulation was performed with a linear precision table and 
servo controlled stepper motor.  The system provides controlled axial motion with 
displacement monitored by a linear variable differential transformer (LVDT).  The rats 
were placed in a sling so that the fixator could be properly aligned, and the locking plate 
was removed once it was secured in the loading device.  Mechanical stimulation occurred 
for five consecutive days beginning at three or 24 days post-operatively at a magnitude of 
±8% strain (±0.16mm) and a rate of 0.313 Hz for 510 loading cycles.  A control group for 
each time point, which had a unilateral, unstimulated osteotomy, was also entered into the 
study.  Rats were euthanized on either day seven or 28, immediately after the final 
application of mechanical stimulation.  All experimental procedures were approved by 
the University of Michigan Committee on Use and Care of Animals. 
Harvest of Callus Tissue 
 Immediately after each animal was euthanized, the callus tissue was removed 
under sterile conditions.  The legs of each animal were shaved, the femora were exposed 
and harvested, and the fracture calluses were removed from the osteotomy using a scalpel 
blade.  After each callus was removed, it was immediately placed in an RNase-free 
microfuge tube and snap frozen in liquid nitrogen.  The harvested tissues were then 
stored at -80°C until they were processed for RNA extraction. 
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Isolation of RNA 
TRIzol reagent (Invitrogen, Carlsbad, California) was used to isolate RNA from 
the harvested samples.  Samples were thawed in 1ml TRIzol on ice, and then 
homogenized using a Polytron disperser (Lucerne, Switzerland).  After the separation of 
the remaining bone tissue from the reagent, 200µl of chloroform was added to separate 
the solution into aqueous and organic phases.  The liquid phase was removed, placed into 
clean tubes, and then the RNA was precipitated out of solution through the addition of 
0.5ml isopropanol.  After centrifugation, the resulting pellet was washed in 75% EtOH, 
dried, and suspended in RNase/DNase free water.  In preparation for RT-PCR, TURBO 
DNA-free (Applied Biosystems/Ambion, Austin, TX) was used to remove genomic DNA 
contamination. 
RT-PCR Array 
 The concentration of RNA for each sample was determined by spectrometer.  All 
of the samples except one, which had a lower concentration, were diluted to a 
concentration of 126 ng/µl.  Samples were examined on an Agilent 2100 bioanalyzer 
(Agilent Technologies, Santa Clara, California) to determine the integrity of the RNA.  
Two, 5µl amounts of each sample were alloquated for analysis, and all experiments were 





 PCR Array System (all components from SABiosciences, 
Frederick, MD) was used for PCR analysis.  The RNA in the 5µl samples was converted 
to cDNA using the RT
2
 First Strand Kit, and the experimental cocktail for RT-PCR was 
created using the RT
2
 qPCR master mix.  A 384-well, custom PCR array was used to 
determine the expression of selected genes.  Each array contained four sets of: a panel of 
84 genes of interest (See Table 4 - 1 and Table 4 - 2), five housekeeping genes, and three 
RNA and PCR quality controls.  The genes of interest were selected through a literature 
search and chosen due to evidence that they are involved in the migration of 
mesenchymal stem cells [5, 18, 19, 22-25, 39-41, 47, 51, 52, 55, 56, 60, 63, 65, 68, 70, 




 Comparisons were made between the stimulated and control fracture gaps within 
each group to determine the effect of displacement on gene expression at each time point.  
To test for the systemic release of factors due to displacement, comparisons were also 
made between the unstimulated control in the bilateral rats and the unstimulated fracture 
in the rats that only had one osteotomy.  The data was normalized to the mean cycle 
threshold (Ct) of the five housekeeping genes for each plate.  All comparisons were made 
using generalized least squares, which takes into account the correlation between the 
technical replicates [71].  Differences were deemed significant for p<=0.05. 
Results 
 In animals that underwent axial displacement starting three days after surgery and 
then were euthanized on day seven, IGF-2, IGF-2 receptor, and Col1a1 were up-regulated 
in the loaded fracture gap versus the contralateral control gap (Table 4 - 3).  HGF and 
angiopoietin-1 were down-regulated in the loaded callus tissue when compared to the 
contralateral control. 
 For animals that were stimulated starting on day 24 and euthanized on day 28, 
CXCL-10 (IP-10), BMP-6, Bglap-2 (BGPR), EGF, and Ihh were all up-regulated in the 
displaced fracture tissue versus the contralateral control (Table 4 - 4).  Several genes 
were also down-regulated in the stimulated callus in comparison to the control including 
IL-8 receptor beta, MMP-8, CX3CR-1, IL-6, and CSF-3. 
 To test for effects that the displaced gap may be having on the distant, control 
fracture, the control fracture tissue from animals that had bilateral osteotomies was 
compared to the fracture gaps from animals that only had one, unstimulated osteotomy.  
HGF, CCL22 (MDC), and TNF-! were up-regulated in tissue from control fractures in 
bilateral rats stimulated starting day three in comparison to the fractures in the unilateral 
model (Table 4 - 5).  IBSP, GDF-5, Col1a1, Ihh, MMP-2, and Fn-1 were all down-
regulated in those animals. 
 For animals euthanized on day 28, FGF-4 and CX3CR-1 were up-regulated in 
control fractures from the bilateral rats versus the fracture tissue from the rats with only 
one osteotomy (Table 4 - 6).  Ihh, BMP-6, CXCL-1, IBSP, FGF-3, CXCL-10 (IP-10), 




 At both time points, both experimental groups showed several differences in gene 
expression in fracture gap tissue.  Genes of all the factors that were chosen for PCR 
analysis show some evidence from previous studies that they can influence the migration 
of mesenchymal stem cells, and these genes can also give insight to how healing is 
progressing in general.  The data show that expression of some genes are up-regulated, 
while the expression for others was down-regulated, suggesting that mechanical 
stimulation can alter chemotactic patterns.  
After undergoing five days of axial displacement, fracture gap tissue harvested 
seven days after surgery showed an up-regulation in insulin-like growth factor-2 (IGF-2), 
the IGF-2 receptor, and type-1 collagen.  This group also expressed lower levels of 
hepatocyte growth factor (HGF, also known as scatter factor) and angiopoietin-1. 
Previous studies have also shown peak mRNA expression of IGF-2 to occur seven days 
after fracture in a mandibular osteotomy model [73].  IGF-2 is known to stimulate the 
production of type-1 collagen, and is important in late-stage endochondral ossification 
[19, 64].  HGF is expressed very early on in fracture healing and plays a role in 
neovascularization as well as BMP signaling [6, 30, 35, 75].  New vessel formation is 
also induced by angiopoietin-1, whose expression has been shown to be increased three- 
to five-fold in the early stages of fracture healing [27, 28, 49] and is also critical in 
distraction osteogenesis [10].  These results suggest that when mechanical stimulation is 
applied at an early time point, displacement encourages type-1 collagen synthesis but 
discourages neovascularization at the fracture site.  This may not be a beneficial 
environment for healing to progress since a good vascular supply is necessary for 
successful repair [14, 78].  These results are also consistent with the findings from the 
data presented in Chapter 2 that showed that fractures exposed to displacement at early 
time points healed at a slower rate than those displaced after the inflammatory phase had 
ended. 
IGF-2, type-1 collagen, and HGF are all known to promote the migration of 
MSCs, whereas the chemotactic effect of angiopoietin-1 on MSCs is not as firmly 
established and it may require VEGF to act as a chemoattractant [55].  The study in 
Chapter 3 on in vivo MSC migration also found that even though there were not many 
 
 79 
cells present in the femora of this group ten days after surgery, there were established 
populations of cells later on at 24 and 48 days.  The results also indicated that there may 
be a greater MSC presence in the stimulated limbs versus the control limbs.  These results 
taken together could suggest that axial displacement is creating a stronger chemotactic 
local environment than in the nondisplaced controls.  Without knowing the relative 
strength of the migration cues or the specific gradients of these chemotactic factors 
through the tissue, it is impossible to definitively say if the expression profile of these 
genes would cause the MSC to preferentially home to one defect over another. 
When controlled displacement is applied 24 days after surgery, there is an 
increased expression of bone morphogenetic protein-6 (BMP-6), osteocalcin (Bglap-2), 
epidermal growth factor (EGF), and Indian hedgehog (Ihh) suggesting that the 
stimulation is promoting endochondral ossification.  BMP-6 and Ihh work together in 
chondrocyte maturation [48, 61] and promote bone formation through endochondral 
ossification [13, 57, 67].  BMP-6 has also been shown to accelerate fracture healing when 
it is injected directly into the defect [3, 36], and induces ectopic bone formation after 
subcutaneous injection [38].  EGF is also thought to be involved in skeletal growth by 
regulating chondrocyte activity [7], and its receptor has been shown to be mechanically 
regulated in osteoblasts undergoing fluid shear in vitro [59].  These results, along with the 
increased expression of osteocalcin, suggest that the applied stimulus is encouraging 
endochondral ossification and mineralization in the regenerating tissue.  It is also 
important to note that the expression of inflammatory factors and proteinases is reduced 
in the stimulated limb.  Interleukins are involved in inflammation and have been 
implicated in osteoclast resorption during diseased states [54], and CX3CR-1 and 
granulocyte colony stimulating factor are pro-inflammatory factors that promote 
monocyte accumulation [17, 58, 69].  Matrix metalloproteinases degrade extracellular 
matrix proteins early in healing [37] and increased serum levels of MMP-8 have been 
detected in patients with non-healing fractures [33].  These results taken as a whole 
suggest that controlled axial displacement applied 24 days after surgery may provide a 
favorable environment for endochondral bone formation. 
 It is possible that applying a controlled stimulus at the site of injury promotes the 
release of soluble factors that can influence remote sites.  In this case, there were many 
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molecular changes detected in the non-stimulated fracture tissue of rats that had a 
stimulated fracture in the contralateral femur.  At post-operative day seven, there was an 
elevation in macrophage and inflammatory factors (CCL22 and tumor necrosis factor-
alpha), and a decrease in factors that are important in fracture repair like Ihh and growth 
differentiation factor-5 (GDF-5) [1, 12].  There was also a decrease in bone extracellular 
matrix proteins type-1 collagen, bone sialoprotein (IBSP), and fibronectin (Fn-1), which 
are typically expressed early in bone healing [86].   
At post-operative day 28, it appears that more chemotactic factors are down-
regulated in the unloaded fracture in the bilateral model versus the unloaded unilateral 
fracture suggesting that the systemic response to displacement is to reduce cell homing to 
distant sites.  Again, without knowing the relative strength of these signals in relation to 
each other, it is not possible to be certain of any directional migration cues.  It also seems 
that the distant site has a decrease in several important healing factors like Ihh, BMP-6, 
IBSP, FGF-3, and GDF-5 when compared to the unilateral defects.  This would suggest 
that the unstimulated site at later time points might be undergoing changes that would 
negatively affect healing.  Clinically, this would only make a difference if the patient had 
two major fractures and only one was treated with a controlled motion.  If mechanical 
stimulation was to be prescribed as a fracture treatment in this case, it would be likely 
that both injuries would be treated, which may eliminate the negative systemic effects. 
Coupling the data from the bilateral comparison with the systemic comparison 
suggests that the axial displacement may be having a bigger influence systemically than 
locally.  For example, at post-operative day 28 more BMP-6 was found in the displaced 
fracture gap in comparison to the contralateral, undisplaced control.  There was also more 
BMP-6 in the gap of the unilateral fracture in comparison to the unstimulated, bilateral 
fracture.  This means that it is possible that the differential expression seen in the loaded 
versus the unloaded fractures in the bilateral animals is actually a systemically induced 
decrease in expression.   
It is evident that mechanical stimulation has an effect on the expression of 
molecular factors in the fracture site.  At seven days post-op, there was a decrease in 
angiogenic factors, and at 28 days, there was an increase in genes implicated in 
endochondral ossification and mineralization on the stimulated side.  There were also 
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differences in expression between unstimulated limbs in a unilateral model and a bilateral 
model suggesting that the applied stimulus is having a systemic effect.  The mechanisms 
by which these changes are occurring are not fully understood.  More studies need to be 
performed to understand the cellular response to strain in vivo and how circulating factors 






Chapter 4 Tables 
 
Symbol Description  Symbol Description 
Cxcl12 
 
Chemokine (C-X-C motif) ligand 12  Ihh Indian hedgehog homolog, (Drosophila) 
Il1a Interleukin 1 alpha  Bglap2 Bone gamma-carboxyglutamate protein 2 
Il1b Interleukin 1 beta  Igf2 Insulin-like growth factor 2 
Il6 Interleukin 6  Fgf1 Fibroblast growth factor 1 
Tnf Tumor necrosis factor  Fgf2 Fibroblast growth factor 2 
Tgfb1 Transforming growth factor, beta 1  Fgf3 Fibroblast growth factor 3 
Tgfb2 Transforming growth factor, beta 2  Fgf4 Fibroblast growth factor 4 
Tgfb3 Transforming growth factor, beta 3  Fgf5 Fibroblast growth factor 5 
Pdgfa Platelet derived growth factor, alpha  Mmp2 Matrix metallopeptidase 2 
Pdgfb Platelet derived growth factor, beta  Mmp7 Matrix metallopeptidase 7 
Bmp1 Bone morphogenetic protein 1  Mmp8 Matrix metallopeptidase 8 
Bmp2 Bone morphogenetic protein 2  Cx3cl1 Chemokine (C-X3-C motif) ligand 1 
Bmp3 Bone morphogenetic protein 3  Cxcl16 Similar to chemokine (C-X-C motif) ligand 16 
Bmp4 Bone morphogenetic protein 4  Mip1 Myocardial ischemic preconditioning 1 
Bmp5_predicted Bone morphogenetic protein 5 (predicted)  Egf Epidermal growth factor 
Bmp6 Bone morphogenetic protein 6  Hbegf Heparin-binding EGF-like growth factor 
Bmp7 Bone morphogenetic protein 7  Tgfa Transforming growth factor alpha 
Cxcl1 Chemokine (C-X-C motif) ligand 1  Hgf Hepatocyte growth factor 
Gdf5 Growth differentiation factor 5  F2 Coagulation factor II 
Gdf8 Growth differentiation factor 8  Ccl2 Chemokine (C-C motif) ligand 2 
Fn1 Fibronectin 1  Ccl5 Chemokine (C-C motif) ligand 5 
Vtn Vitronectin  Ccl22 Chemokine (C-C motif) ligand 22 
Col1a1 Procollagen, type 1, alpha 1  Lif Leukemia inhibitory factor 
Angpt1 Angiopoietin 1  Ntf3 Neurotrophin 3 
Angpt2 Angiopoietin 2  Pgf Placental growth factor 
Vegfa Vascular endothelial growth factor A  Cxcl10 Chemokine (C-X-C motif) ligand 10 
Vegfb Vascular endothelial growth factor B  Csf2 Colony stimulating factor 2 (gran-macrophage) 
Vegfc Vascular endothelial growth factor C  Csf3 Colony stimulating factor 3 (granulocyte) 
Igf1 Insulin-like growth factor 1  Ibsp Integrin binding bone sialoprotein 
Cd44 CD44 antigen  Flt1 FMS-like tyrosine kinase 1 
 
Table 4 - 1: List of ligands used for PCR analysis.  These ligands were chosen based on evidence from the literature that they promote 





Cx3cr1 Chemokine (C-X3-C) receptor 1 
Bmpr1a Bone morphogenetic protein receptor, type 1A 
Bmpr1b Bone morphogenetic protein receptor, type 1B (mapped) 
Bmpr2 Bone morphogenic protein receptor, type 2 
Igf1r Insulin-like growth factor 1 receptor 
Igf2r Insulin-like growth factor 2 receptor 
Pdgfra Platelet derived growth factor receptor, alpha polypeptide 
Pdgfrb Platelet derived growth factor receptor, beta polypeptide 
Kdr Kinase insert domain protein receptor 
Ccr1 Chemokine (C-C motif) receptor 1 
Ccr2 Chemokine (C-C motif) receptor 2 
Ccr4 Chemokine (C-C motif) receptor 4 
Ccr7 Chemokine (C-C motif) receptor 7 
Il8rb Interleukin 8 receptor, beta 
Cxcr3 Chemokine (C-X-C motif) receptor 3 
Cxcr4 Chemokine (C-X-C motif) receptor 4 
Cxcr6 Chemokine (C-X-C motif) receptor 6 
Fgfr1 Fibroblast growth factor receptor 1 
Fgfr2 Fibroblast growth factor receptor 2 
Fgfr3 Fibroblast growth factor receptor 3 
 
Table 4 - 2: List of receptors used for PCR analysis.  These receptors were chosen based 
on evidence from the literature that they promote the migration of mesenchymal stem 





Up-regulated gene Up p value  Down-regulated gene Down p value 
IGF-2 0.0179  HGF 0.0257 
Col1a1 0.0197  Angiopoietin-1 0.0479 
IGF-2 receptor 0.0213    
 
Table 4 - 3:  Differential gene expression in rats with bilateral osteotomies that received 
unilateral displacement and were euthanized on post-operative day seven.  These genes 
were either up- or down-regulated in the stimulated fracture gap of animals with one 
fracture displaced starting on post-operative day three in comparison to the contralateral, 




Up-regulated gene Up p value  Down-regulated gene Down p value 
CXCL10/IP-10 0.0095  IL-8 receptor beta 0.0116 
BMP-6 0.0140  MMP-8 0.0160 
Bglap-2/BGPR 0.0161  CX3CR-1 0.0204 
EGF 0.0438  IL-6 0.0252 
Ihh 0.0451  CSF-3 0.0412 
 
Table 4 - 4: Differential gene expression in rats with bilateral osteotomies that received 
unilateral displacement and were euthanized on post-operative day 28.  These genes were 
either up- or down-regulated in the stimulated fracture gap of animals with one fracture 
displaced starting on post-operative day 24 in comparison to the contralateral, 




Up-regulated gene Up p value  Down-regulated gene Down p value 
HGF 0.0292  IBSP  0.0003 
CCL22/MDC 0.0311  GDF-5 0.0003 
TNF-! 0.0357  Col1a1 0.0025 
   Ihh 0.0036 
   MMP-2 0.0050 
   Fn-1 0.0115 
 
Table 4 - 5:  Genes involved in a systemic response to axial displacement on post-
operative day seven. These genes were either up- or down-regulated in the unstimulated 
control fracture gap of animals with bilateral osteotomies in comparison to the gap tissue 




Up-regulated gene Up p value  Down-regulated gene Down p value 
FGF-4  0.0120  Ihh 0.0001 
CX3CR-1 0.0482  BMP-6 0.0100 
   CXCL-1 0.0159 
   IBSP 0.0168 
   FGF-3 0.0236 
   CXCL-10/IP-10 0.0332 
   GDF-5 0.0353 
   CSF-3 0.0419 
 
Table 4 - 6:  Genes involved in a systemic response to axial displacement on post-
operative day 28. These genes were either up- or down-regulated in the unstimulated 
control fracture gap of animals with bilateral osteotomies in comparison to the gap tissue 
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 Normally, fractures heal without many complications or the need for major 
clinical intervention.  However, the incidence of long-bone non-union is between 5% and 
20% [11], and the health care cost for these cases is on the rise [1].  In addition, the 
advent of advanced body armor has increased survival of soldiers in warfare, but has also 
increased the number of complicated musculoskeletal injuries that need to be treated [4, 
6, 7, 10].  To better treat these injuries, methods need to be developed to accelerate 
fracture repair and reduce complications in difficult cases.  While there is a very good 
understanding of the cellular processes that occur during healing, it is not well known 
how these processes respond to environmental cues. 
 The local mechanical environment is one of the cues that is known to play an 
important role in the healing of fractures, but the mechanisms by which the cells in the 
defect sense and respond to this environment is still poorly understood.  One of the 
reasons for this is the wide array of possible variables that can affect healing.  Different 
and complicated fracture geometries can make it difficult to standardize results between 
experiments.  The magnitude and direction of the stimulation, strain rate, frequency, 
duration, and rest insertion periods can all vary between studies making it difficult to 
compare results from experiment to experiment.   
 Due to differences in these experimental parameters and the inherent variability in 
fracture healing, even concepts that are generally accepted as far as the mechanical 
environment and fracture repair have evidence to the contrary.  For example, there is 
strong evidence in the literature, including this thesis, that controlled motion at the site of 
fracture has an influence on healing.  Even so, other research has demonstrated that 
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motion has no influence on healing progression [2, 3, 13, 14].  It is also generally thought 
that tensile strains lead to direct bone formation, while compression leads to cartilage 
formation and endochondral ossification [5, 9].  Yet, research from our lab has shown the 
opposite, that areas of tension lead to cartilage formation and compression promotes 
intramembranous bone formation [12].  These two examples demonstrate that variability 
between models and in fracture healing in general can lead to different results. 
 Keeping in mind the wide array of parameters that can be varied, this dissertation 
set out to determine the effect of a reversible, axial displacement applied at 8% strain.  
This strain was chosen based on work in our laboratory that showed that 8% strain was an 
acceptable level of stimulation and elicits a response [12].  A rate of 0.313 Hz over 510 
cycles for five consecutive days was also chosen, and for the most part, these were all 
held constant for all of the experiments.  The only parameter that varied throughout was 
when the displacement was applied with respect to the day of surgery.  To change any 
more parameters than one would have led to a much more complicated experiment, and 
with the variability, the size of the experiment would have had to be much larger to 
achieve statistical significance.  Any experiment that would try to tie together a majority 
of the variables mentioned above would be impossibly large, and for that reason, this 
dissertation tried to answer important questions by varying only one parameter.  Namely, 
this work tried to answer how the timing of the application of the axial stimulus effects 
fracture healing.  It also shed light on how the stimulus and its timing effects the homing 
dynamics of mesenchymal stem cells (MSCs).      
 Chapter 2 focused on the effects that the mechanical stimulus had on callus 
morphology, and how the timing of the stimulus had differential effects on tissue 
formation.  Timing was shown to have a significant effect on the progression of healing.  
The fracture calluses from animals that had axial displacement applied starting ten days 
after surgery had more mineralization and showed signs of earlier remodeling when 
compared to other groups.  Stimulation had the opposite effect on animals that were 
displaced starting on day three, and these gaps showed signs of delayed healing.  In the 
early stages of healing, the fracture is beginning to revascularize, and it could be that by 
displacing the fracture at day three, new vessels that are needed for healing to progress 
are being disrupted.  However, after new vasculature has been allowed some time to take 
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root, it may be that the mechanical stimulation is sensed by the cells that are present in 
the gap and a subsequent stimulatory response is triggered. 
One of the most interesting findings from this study is that the applied 
displacement appears to have a systemic response.  When displacement is applied to the 
fracture on one side, the same effects can be seen on the gap on the contralateral side, 
which was not stimulated.  This could be from a release of soluble factors into the 
circulation that then affect the gap on the other side.  If the displacement releases factors 
locally, either inhibitory or stimulatory, these factors may then be transported to the 
opposite side and therefore have the same effect. 
In all of the animals, mesenchymal stem cells were systemically injected via the 
tail vein immediately before the onset of axial displacement.  The central point of 
Chapter 3 was tracking the migration of these cells.  Cells tagged with 
111
indium and 
tracked with planar gamma imaging were used to determine the short-term fate of the 
injected cells.  In the first two days of axial displacement, there were some differences 
due to load, but these seem to be transient as they all disappeared by day three.  The most 
pronounced difference occurred when the injection of cells was delayed until day four.  
These animals showed significantly less cellular presence in the femora than their 
counterparts that had cells injected on day one, but again this was a transient response 
that disappeared the next day.  The half-life of 
111
indium is around three days, so the 
transient nature of the response could also be due to a loss of sensitivity as the radiolabel 
decays. 
Immunohistochemistry (IHC) was used to track the fate of the injected cells in the 
long term.  The results showed that the cells do not take residence in the marrow early on, 
but as healing progresses, a large population of cells is present in the femora.  Even 
though there are MSCs within all of the tissues in the femora, the majority of the cells are 
found in the marrow.  It is also notable that unless the fracture had progressed far enough 
to contain marrow within the gap itself, that MSCs were rarely found in the actual gap.  
This is a reasonable result, considering that the main MSC niche is within the marrow 
and the cambium layer of the periosteum.  It also seems that there may be more MSCs in 
the stimulated femur as compared to the unstimulated control.  This result is hard to 
verify though considering that the outcome was measure qualitatively. 
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There were very few MSCs located in the marrow of the group that underwent 
displacement on day ten.  This is significant because it corresponds to the group that had 
the most advanced healing by micro-CT and histology analysis.  It seems counter 
intuitive that a lack of MSC activity would correspond to accelerated fracture repair (or 
alternatively that MSC activity leads to retarded healing).  The response though could 
stem from interaction with the immune system.  It could be that the injected MSCs are 
eliciting an immune response since the injected cells did not come from syngeneic 
animals, and this response could be inhibiting repair.  There is also evidence that MSCs 
inhibit T-cell proliferation, and the action of the T-cells may be necessary for fracture 
healing to normally progress.   
Chapter 4 examined data from a polymerase chain reaction (PCR) array to try to 
begin to understand what underlying molecular processes may be behind the response to 
mechanical signals in fracture healing.  This array was unique in that it allowed for the 
analysis of a wide variety of genes, like a small gene chip, with the validation of PCR.  
All of the genes of interest that were chosen have some relation to the migration of 
mesenchymal stem cells.  The analysis showed differences in gene expression between 
the displaced and the control gaps, and it showed a strong systemic response.  It is 
difficult to say what overall chemotactic effect the genetic expression pattern has on 
MSC migration, but the early PCR data coupled with the immunohistochemistry results 
suggest that the axial displacement may provide a favorable environment for MSC 
homing.  Without knowing the relative strength of each signal and how potent each 
homing factor is, it is difficult to know the overall effect. 
Even though the genes of interest in the PCR study were selected based on MSC 
migration literature, the results also validate the data on callus morphology.  Angiopoietin 
and hepatocyte growth factor both had lower expression in the stimulated gap of the 
animals that underwent stimulation early in the repair process.  This suggests that 
neovascularization, which is crucial in the early stages of healing, may be hindered.  
When the displacement is applied at a later time point, bone morphogenetic protein-6, 
epidermal growth factor, and Indian hedgehog have a higher expression and 
inflammatory factors have a lower expression in the stimulated gap.  This suggests that if 
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displacement is applied later on that endochondral bone formation is promoted while 
inhibitory inflammatory factors are down regulated by load. 
As a whole, the evidence from this dissertation suggests that mechanical 
stimulation is beneficial if it is applied after the fracture has had time to reestablish 
vasculature as well as begin to form some supporting tissue.  After fracture, it is critical 
to healing for the callus to reconnect with the blood supply.  If the load is applied too 
early, in the case of these studies zero to three days after injury, the blood vessels that are 
trying to form are continually being torn apart and are not allowed to establish a good 
vascular network.  This demonstrates that a mechanical stimulus should not be applied 
too soon after bony injury.  
Mechanical stimulation is known to have a positive effect if applied under the 
correct set of conditions.  The calluses that were stimulated after ten days showed more 
advanced signs of healing (more mineral and less cartilage by day 48) and had less of an 
MSC presence.  It could be that the cellular milieu that is present after ten days of healing 
is more receptive to load than at other time points.  Chondrocytes are known to be 
responsive to mechanical stimuli and when loaded have been shown to enhance fracture 
healing.  It is also possible that early in fracture healing, when granulation tissue 
dominates the fracture callus, that the strain and fluid shear magnitudes are much higher 
in the absence of a stiff matrix [8].  As the fracture is allowed time to heal, the overall 
shear strain is decreased to a level conducive to promotion of healing.  Based on the work 
in this dissertation, it seems that a beneficial regimen of mechanical stimulation can be 
applied during the soft callus phase of fracture repair. 
All of the results from this work also showed a systemic response to the local 
application of axial displacement.  Data from micro-CT, histology, mechanical testing in 
torsion, and PCR all confirmed that this systemic effect is occurring.  The stimulation is 
probably releasing soluble factors into the circulation that then become available to the 
fracture in the distant limb.  If a clinical treatment is developed to aid in fracture repair 
and it is applied at a distant site, the magnitude and the timing of the mechanical load 
could be very different from that applied in this dissertation.  It would not matter if the 
treatment was applied soon after fracture if it would not disrupt neovascularization.  In 
fact, it may be beneficial to have an early stimulus if the local structure of the healing 
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callus did not need to be disrupted.  The understanding of this systemic effect could 
potentially play an important role in studying and treating bone fractures in the future.   
The set of experiments in this work were not without their problems and 
limitations, and there are several things that could be done in future works to improve 
upon the experimental design.  The first major hurdle that needed to be overcome in the 
analysis was the large amount of variability in the data.  Fracture healing by nature is a 
variable process sensitive to many variable conditions.  This is especially true with the 
2mm segmental defect model used in this work.  The 2mm defect is significantly large, 
but not a critical sized defect.  With a 2mm osteotomy, the defect will heal without any 
additional factors or scaffolding.  This defect is large enough though that without every 
condition, like gap placement, pin placement, and the height of the fixator on the pins, 
held exactly the same from fracture to fracture, which is impossible to do, that there is an 
inherent variability that is not controllable.  It may be beneficial for future studies to 
consider using a unilateral segmental defect.  This would increase the amount of rats that 
would be necessary to complete the study, but it will reduce some of the variability.  With 
only one defect to create, there are fewer chances for complications from surgery.  A 
model with only one fracture would also reduce the noise created from systemic effects, 
as the unstimulated, control fractures would be in separate animals.  
The histology for this study also proved to be challenging.  The original goal for 
the determination of the long-term fate of the mesenchymal stem cells was to use 
fluorescent microscopy to track the cells.  In order to better visualize the cells through 
fluorescence, the femora were all embedded in poly(methyl methacrylate) instead of 
paraffin, which is known to auto fluoresce in the green fluorescent protein (GFP) range.  
What was not expected though was the strong auto fluorescence from the bone itself.  
This made it impossible to detect the cells through fluorescence since the signal to noise 
ratio would be small, especially considering the limited populations of MSCs that 
eventually made it to the femora.  Due to this noise, IHC was used to locate the cells 
within the bones.  Both the histology and the IHC would be more efficient and of a much 
higher quality if it was done in paraffin.  Future work should consider these 
complications and may want to embed the specimens in paraffin and plan to use IHC to 
identify the GFP positive MSCs that migrate to the bones. 
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One other technique that could be explored for future studies is the use of in vivo 
micro-CT to perform a longitudinal study on the time course of fracture healing.  The 
fixators were made from PEEK so that they could be radio-translucent for this reason.  
Unfortunately, the metal from the pins provided enough scanning artifact to make the 
images difficult to read.  In addition, the in vivo micro-CT scanner has a lower resolution 
than the ex vivo scanner does, which would make it even more difficult to detect 
differences in a high variability model.  If a reliable protocol could be developed to 
utilize the in vivo scanner to answer fracture-healing questions, a comprehensive study 
could be completed using a half of the number of rats and half of the time required to 
complete the experiments outlined in this dissertation.  Care will have to be taken to 
balance the noise and resolution issues of the in vivo scanner, and proper hypotheses will 
have to be chosen to be analyzed considering these issues.  Special equipment might also 
need to be built to help align the pins in the plane of the scan, which would reduce the 
artifact that is created when the pins are out of plane. 
The work in this dissertation has answered questions about how axial 
displacement effects callus morphology and torsional strength and how systemically 
delivered cells respond to the fracture environment.  It also began to answer questions 
about the molecular nature of the cellular response.  There are several experiments that 
could be done in the future to build on this work. 
The first would be to validate the chemotactic response of MSCs to the factors 
that were either up- or down-regulated by mechanical stimulation.  Even though the 
genes of interest in the PCR array study were chosen from evidence in the literature that 
they can promote the directed migration of MSCs, this should be validated.  It would be 
possible to validate the chemotactic response of MSCs to all of the detected factors in one 
experiment to generate data on the potency of their individual effects relative to each 
other.  Using a modified Boyden chamber, the bottom wells of each chamber could be 
filled with media containing each detected factor in the same concentrations.  The relative 
chemotactic index could then be determined for each factor.  Then, the relative 
chemotactic intensities for each growth factor or chemokine would be known.  It still 
would not answer how much of each protein was physically present in the fracture tissue, 
but it would answer which has the highest relative potency.   
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Using information from the Boyden chamber to focus on proteins of interests, it 
could be determined what cells are producing those proteins and in what concentrations.  
IHC could be used to localize protein presence in the cells of the callus and to make an 
estimation of how much of each protein is present.  The information from the Boyden 
chamber tests and the IHC could then be used as a starting point for in vivo experiments 
of MSC migration.  The actual form of the in vivo experiment might be dependent on the 
actual proteins that turned out to be the most potent chemoattractants, the proteins that 
were found to have high concentrations in the fracture callus, or a combination of the 
two.  Depending on the factors chosen, the experiments could then look at MSC 
migration to the site of injury in either a knockout mouse model, a locally injected 
protein, or a matrix seeded with the factor of interest. 
Another interesting question that has yet to be answered is what role the injected 
MSCs are playing in fracture healing.  It would be reasonable to assume that the majority 
of the cells that were detected by the planar gamma imaging did not actively participate 
but instead had some other role since at ten days post-op there were very few cells 
detected by IHC.  Most of the cells that were detected by IHC were found in the marrow 
and did not show any evidence that they had differentiated.  The data also suggested that 
the injected cells may have actually inhibited healing progression.  One possible scenario 
that could cause this is an alteration in the inflammatory response by the MSCs.  To 
determine if the MSCs are playing a role in the inflammatory response, IHC could be 
used to determine the status of the inflammatory cell population.  It is possible that the 
host rat is trying to reject the cells and therefore there will be more immune cells present.  
It is also possible that the MSCs are hindering T-cell proliferation and there will be few 
immune cells present.  It could also be that the cells are increasing the inflammatory 
response early on, but inhibiting it later, and a study using IHC could answer these 
questions. 
An intriguing result from this dissertation was the finding that the promotion of 
fracture healing is a systemic event.  Essentially, what happened in one femur also 
happened in the other.  This result could have a translational application.  It is possible 
that mechanical stimulation at a distant, intact site could promote fracture healing.  A 
study could be done in mice or rats with a femoral fracture or segmental osteotomy along 
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with ulnar loading.  At set time points after the creation of the fracture, the animal would 
undergo a weeklong regimen of ulnar loading.  Measures of fracture healing through 
micro-CT, histology, and torsional mechanical testing could be made to determine if the 
ulnar loading has an effect on healing versus an unloaded control group.  If a positive 
effect on healing was found, the results could then be extended to clinical applications.  It 
could be feasible that, in humans, a finger could undergo mechanical stimulation to 
promote not only fracture healing, but could help promote bone formation in osteoporotic 
patients.  It could also be used as a countermeasure for astronauts to help reduce bone 
loss during long-term space flight, in which they will lose 1-2% of their bone mass per 
month while in space.      
 This dissertation has shown that the timing of the application of a mechanical 
stimulus can play a role in the progression of healing in a fractured bone.  An axially 
applied displacement had a beneficial effect on mineralization and the progression of 
remodeling in animals that were stimulated after ten days when compared to other 
stimulus timings.  The opposite was true of animals that were stimulated starting on day 
three.  Mesenchymal stem cells were also injected into these animals, and it was found 
that the cells took residence in the marrow spaces of all the animals after 48 days, with 
the exception of the animals stimulated starting on day ten.  The data also suggest that 
these exogenous cells may not be beneficial for fracture healing, as seen in the groups 
stimulated on day 24.  Finally, a PCR array was used to start to elucidate any alterations, 
caused by axial displacement, in the molecular factors that are involved in fracture repair 
as well as well as MSC migration.  It was found that the applied stimulus causes changes 
in genetic expression of several important factors, both locally and systemically. 
 This work has advanced knowledge with regard to the mechanical environment 
and cellular and tissue responses in fracture healing.  Future work is needed to determine 
what cells are responding to this environment as well as the mechanism by which those 
cells are responding to the mechanical stimuli.  Once these processes are better 
understood, this knowledge could then be translated into clinical interventions to help 
repair moderate to severe fractures as well as measures to counteract bone loss for 
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